{
  "name" : "moscow.sci-hub.se_5389_81c1a74ad971c345174c2a91ad208eba_phelps2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Title: Aberrant accumulation of the diabetes autoantigen GAD65 in Golgi membranes in conditions of ER stress and autoimmunity Short running title: ER stress-induced Golgi accumulation of GAD65",
    "authors" : [ "Edward A. Phelps", "Chiara Cianciaruso", "Iacovos P. Michael", "Miriella Pasquier", "Jamil Kanaani", "Rita Nano", "Vanessa Lavallard", "Nils Billestrup", "Jeffrey A Hubbell", "Steinunn Baekkeskov" ],
    "emails" : [ "steinunn.baekkeskov@epfl.ch" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Pancreatic islet beta cells are particularly susceptible to endoplasmic reticulum (ER)\nstress, which is implicated in beta cell dysfunction and loss during the pathogenesis of type 1 diabetes (T1D). The peripheral membrane protein GAD65 is an autoantigen in human T1D. GAD65 synthesizes GABA, an important autocrine and paracrine signaling molecule and a survival factor in islets. We show that ER stress in primary beta cells perturbs the palmitoylation cycle controlling GAD65 endomembrane distribution, resulting in aberrant accumulation of the palmitoylated form in trans-Golgi membranes. The palmitoylated form has heightened immunogenicity, exhibiting increased uptake by antigen presenting cells and T cell stimulation compared to the non-palmitoylated form. Similar accumulation of GAD65 in Golgi membranes is observed in human beta cells in pancreatic sections from GAD65 autoantibody positive individuals, who have not yet progressed to clinical onset of T1D, and T1D patients with residual beta cell mass and ongoing T cell infiltration of islets. We propose that aberrant accumulation of immunogenic GAD65 in Golgi membranes facilitates inappropriate presentation to the immune system following release from stressed and/or damaged beta cells, triggering autoimmunity."
    }, {
      "heading" : "INTRODUCTION",
      "text" : "The GABA-synthesizing enzyme glutamic acid decarboxylase (GAD) exists in two isoforms, GAD65 and GAD67, encoded by different genes (1). The smaller isoform, GAD65, is an early target of autoimmunity in 70-80% of patients who develop T1D (2-4). Rat and human beta cells primarily express GAD65, while no GAD65 is detected at the protein level in mouse beta cells (5; 6). Our understanding of how GAD65 becomes an autoantigen in T1D is limited due to the lack of this protein in beta cells of mice, and therefore an apparent lack of a significant role in the pathogenesis of diabetes in the highly studied NOD mouse model of T1D (7).\nThe GAD65 enzyme is synthesized in the cytosol as a hydrophilic cytosolic molecule,\nwhich undergoes hydrophobic post-translational modifications in the N-terminal domain to become membrane anchored (8-11). The first step of hydrophobic modifications is irreversible and results in a hydrophobic form that targets specifically to the cytosolic face of endoplasmic reticulum (ER) and cis-Golgi membranes, establishing an equilibrium between membrane and cytosolic pools (12). The second step of modifications, which include stabilization of membrane anchoring followed by a reversible double palmitoylation of cysteines 30 and 45 (10) by a Golgi localized protein acyl transferase (PAT) DHHC17 (also known as HIP14) (13), result in trapping of GAD65 in Golgi membranes, sorting to the trans-Golgi network (TGN) and targeting to an axonal vesicular pathway in route to synaptic vesicles in presynaptic clusters in neurons and to peripheral vesicles in beta cells (12; 14; 15). Palmitoylation is not required for anchoring of GAD65 to Golgi membranes but is critical for anterograde targeting of GAD65 from cis-Golgi to TGN membranes and post-Golgi peripheral vesicles (12). A depalmitoylation step by an acyl protein thioesterase (APT) can release GAD65 from peripheral vesicle membranes and/or TGN membranes mediating retrograde trafficking back to Golgi membranes by a non-vesicular\npathway. The protein can then enter a cycle of re-palmitoylation and de-palmitoylation (12). Palmitoylation is suggested to serve a critical function in regulating the rate of GABA synthesis in the presynaptic compartment of neurons (16; 17).\nPancreatic beta cells have a well-developed, extensive, and highly active ER, reflecting\ntheir role in synthesizing and secreting large amounts of insulin. When the protein synthesis and secretion machinery becomes overloaded, either due to a high physiological demand on a limited number of cells or from exogenous stressors such as inflammation or a diet high in fatty acids, the accumulation of unfolded and improperly folded proteins transiting through the ER results in the cell experiencing a state of ER stress (18). Beta cells are highly sensitive to ER stress, which is implicated in the pathogenesis of T1D (19-22). It has been proposed that the initiation of autoimmunity against the beta cell follows an initial period of prolonged beta cell ER stress and apoptosis, induced by inflammatory cytokines secreted by early invading immune cells as well as the beta cells themselves (19; 23).\nHere we report a dramatic effect of ER stress on the subcellular distribution of the T1D\nautoantigen GAD65 in primary rat and human beta cells and accumulation of a more highly immunogenic palmitoylated form in Golgi membranes. A similar accumulation is detected in pancreatic sections of human GAD65 autoantibody positive individuals and T1D patients."
    }, {
      "heading" : "RESEARCH DESIGN AND METHODS",
      "text" : ""
    }, {
      "heading" : "Cell cultures",
      "text" : "INS-1E rat insulinoma cells (24) were cultured in RPMI 1640 with GlutaMAX, 10%\nFBS, 1% Penicillin/Streptomycin (P/S), 1 mM sodium pyruvate, 10 mM HEPES, and 50 µM βmercaptoethanol. The DR4 (DRA1*0101, DRB1*0401) positive human EBV-transformed B cell line Priess (25) was cultured in IMDM GlutaMAX medium with 10% FBS, and 1% P/S. A DR4 (DRA1*0101, DRB1*0401) restricted mouse T cell hybridoma cell line T33.1, recognizing the GAD65 aa 274-286 epitope (GAD65274-286) (26), was cultured in RPMI 1640 with GlutaMAX, 10% FBS, 1% P/S, and 0.1% β-mercaptoethanol. Primary rat hippocampal neurons were prepared from 2- to 3-day-old Sprague Dawley rats as described by Codazzi et al (27)."
    }, {
      "heading" : "Islet culture",
      "text" : "Rat islets isolated from P5 Sprague Dawley rats as previously described (15) were\ncultured in RPMI 1640, 10% FBS, and 1% P/S at 37°C, 5% CO2. Human islets were cultured in CMRL 1066 with 2 mM L-Glutamine, 25 mM HEPES, 10% FBS, and 1% P/S at 25°C, 5% CO2.\nIslet single cell cultures\nRat or human islets dissociated into single cells by digestion with trypsin-EDTA were\ncultured at 50,000 cells/well on laminin-coated Thermanox coverslips (Nunc) or 100,000 cells/well on Fluorodishes (World Precision Instruments) in MEM, 11 mM glucose, 5% FBS, 1 mM Sodium Pyruvate, 10 mM HEPES, 1X B-27 (Gibco), and 1% P/S at 37°C, 5% CO2."
    }, {
      "heading" : "Human pancreatic sections",
      "text" : "Human pancreatic sections were obtained from the Juvenile Diabetes Research Foundation (JDRF) Network for Pancreatic Organ Donors with Diabetes (nPOD) tissue bank (28; 29). Sections were obtained from 8 autoantibody negative healthy donors with normal islets (Supplementary Table 1), 8 potentially prediabetic individuals positive for GAD65 autoantibodies (GADA+) (Supplementary Table 2), and 8 autoantibody positive T1D patients, including 6 who were GADA+ (Supplementary Table 3). Donors were selected to have remaining insulin positive beta cells to enable analyses of the subcellular localization of GAD65. Furthermore, we sought to include individuals, who were reported by nPOD as positive for CD3+ T cell infiltration and/or insulitis (Supplementary Tables 2 and 3). Insulitis is defined by nPOD as the presence of 6 or more CD3+ T cells immediately adjacent to or within 3 or more islets of a defined minimum size in pancreatic sections (30)."
    }, {
      "heading" : "Immunofluorescence staining",
      "text" : "Human pancreas sections were deparaffinized followed by acidic-pH heat-mediated\nantigen retrieval. Cultures of single pancreatic islet cells were fixed with 4% PFA. Samples were blocked and permeabilized in PBS + 0.3% Triton X-100, 10% goat or donkey serum. Primary antibodies (CHOP, Santa Cruz, sc-575, 1:100; GAD6, mouse monoclonal antibody against Cterminus of GAD65 (31), 1:1000; N-GAD65 mAb, mouse monoclonal antibody against Nterminus of GAD65 (32), 1:300; Giantin, Abcam, ab24586, 1:1000; Insulin, Linco 4011-01, 1:10,000; Insulin, Abcam, ab14042, 1:2,000; CD3, Dako M7254, 1:30) were incubated overnight at 4°C in PBS + 0.3% Triton X-100, 1% goat or donkey serum. Alexa Fluor\nconjugated secondary antibodies (Molecular Probes) were incubated at 1:200 dilution in PBS + 0.3% Triton X-100 for 30 min at room temperature.\nImage capture, analysis, and quantification\nSamples were imaged on a Zeiss LSM700 confocal microscope with 63x/1.40 NA Plan-\nApochromat oil-immersion objective for single islet cells and 40x/1.30 NA Plan-Apochromat oil-immersion objective for pancreatic tissue sections. All images for quantification within a single experiment were captured with the same laser power and detector gain. The ratio of GAD65 mean fluorescence intensity in the Golgi compartment and post-Golgi vesicles compared to the rest of the cytosol was calculated with a custom ImageJ macro. Individual beta cells in a given field of view were identified and outlined by hand. For each cell, the macro automatically defined a region of interest (ROI) outlining the Golgi compartment, identified by giantin co-stain or by characteristic morphology and brightness thresholding of GAD65 stain, and GAD65+ vesicles, identified by brightness thresholding of GAD65+ bright puncta. A second ROI defined the remainder of the cell, excluding the Golgi, GAD65+ vesicles, and nucleus. GAD65 Golgi accumulation was reported as the ratio of mean fluorescence intensity (MFI) for the two ROIs."
    }, {
      "heading" : "SDS-PAGE and Western Blotting",
      "text" : "Gel electrophoresis was performed with the NuPAGE system (Invitrogen) with transfer\nonto PVDF membranes with the iBlot 2.0 (Life Technologies) device. Membranes were blocked with Odyssey Blocking Buffer (LI-COR Biosciences), incubated in primary antibody (GAD1701, a custom antibody against C-terminus of GAD67 that reacts equally well with\nGAD65 and GAD67 (5), 1:5000) overnight at 4°C, and detected with secondary antibody IRDye 800CW (LI-COR Biosciences). Blots were imaged on the LI-COR Odyssey scanner.\nTreatment of cells to induce ER stress\nSodium palmitate (1 mM) (Sigma-Aldrich) was conjugated to fatty-acid-free BSA (0.17\nmM) (Calbiochem) in 150 mM NaCl pH 7.4 for 1 h. Stock palmitate-BSA (1 mM palmitate, 0.17 mM BSA) was added to culture media to achieve a final palmitate concentration of either 0.1 mM or 0.5 mM. A stock solution of BSA (0.17 mM BSA) without palmitate was added to the control (untreated) wells. Thapsigargin (Invitrogen) was used at a final concentration of 2 µM. Rat IFNγ and rat IL-1β (R&D Systems) were used at a final concentration of 10 U/ml for each.\nFluorescence recovery after photobleaching imaging and analysis\nFluorescence recovery after photobleaching (FRAP) experiments were performed on a\nZeiss LSM700 confocal microscope with environmental stage at 512x512 pixel resolution, 1% laser power and 1.94 s frame interval. GAD65-GFP fluorescence in the Golgi compartment of transfected cells, treated or not to induce ER stress, was bleached with 50% laser power. Timestacks of GAD65-GFP fluorescence recovery in the Golgi compartment were double normalized for percentage of initial intensity and whole cell photobleaching in ImageJ. Two-phase and single-phase association curves were plotted in Graphpad Prism to obtain half-time of recovery.\nS-acylation resin-assisted capture (Acyl Rac) palmitoylation assay\nAcyl-RAC on recombinant human GAD65 (rhGAD65, FIRS Laboratories, RSR) was\nperformed as described by Forrester, et al. (33)."
    }, {
      "heading" : "Uptake of GAD65-488 by Priess Cells",
      "text" : "rhGAD65 was depalmitoylated overnight by treatment with 200 mM HA and labeled\nwith DyLight 488 NHS Ester (Thermo Fisher Scientific). Palmitoylated or depalmitoylated GAD65-488 was incubated at 10 µg/ml with 50,000 Priess cells/well in 96-well plates. Cells were stained with LIVE/DEAD® Aqua (Molecular Probes) and analyzed by Cyan Flow Cytometer (Beckman Coulter) and FlowJo software."
    }, {
      "heading" : "Activation of GAD65-specific T cells",
      "text" : "Unmodified rhGAD65 containing native palmitate modifications or HA-treated\ndepalmitoylated GAD65 were incubated overnight with 50,000 Priess cells/well at 2 µg/ml in 96-well plates. GAD65 loaded Priess cells were then incubated for 24 h with 30,000 T33.1 T cells. IL2 secretion was analyzed by ELISA kit (eBioscience)."
    }, {
      "heading" : "Plasmids",
      "text" : "Generation of GAD65-GFP and GAD65(C30,45A)-GFP was described previously (11;\n12; 14). INS-1E and primary rat islet cells were transfected by Lipofectamine 2000 (Invitrogen)."
    }, {
      "heading" : "Statistics",
      "text" : "Means among three or more groups were compared by analysis of variance (ANOVA) in\nGraphPad Prism 6 software. If deemed significant, Tukey’s post-hoc pairwise comparisons were performed. Means between two groups were compared using Student's t-test. A confidence level of 95% was considered significant."
    }, {
      "heading" : "Ethical approval",
      "text" : "Animals were used under EPFL animal regulation guidelines and an IACUC approved\nprotocol. Human islets were received from the University Hospital of Geneva and San Raffaele Scientific Institute, Milan through the European Consortium for Islet Transplantation (ECIT) islets for basic research program ECIT and were approved by the Institutional Review Board of the University Hospital of Geneva (CER Nr. 05–028) and by the Ethics Committee of the San Raffaele Scientific Institute of Milan (IPF002-2014). Human pancreatic sections obtained via the nPOD tissue bank, University of Florida, Gainesville, FL, USA were harvested from cadaveric organ donors by certified organ procurement organizations partnering with nPOD in accordance with organ donation laws and regulations and classified as “Non-Human Subjects” by the University of Florida Institutional Review Board (28; 29). EPFL grants permit for the use of human material as long as the provider can certify that the samples were obtained according to local laws and regulations, as well as good practices in the country were they were collected."
    }, {
      "heading" : "RESULTS",
      "text" : ""
    }, {
      "heading" : "ER stress results in accumulation of GAD65 in the Golgi compartment",
      "text" : "Primary rat and human beta cells derived from dissociated whole islets were cultured as\nmonolayers on coverslips to allow for high-resolution confocal microscopy. The monolayer islet cells were fixed and immunostained for insulin, GAD65, and the Golgi marker giantin (Figure 1). As previously reported (15), GAD65 is detected diffuse in the cytosol as well as in Golgi membranes and post-Golgi vesicles in beta cells. Insulin is detected in distinct large dense core vesicles (LDCVs).\nTo induce mild ER stress, primary islet cell monolayers were subjected to a 48 h time\ncourse of low levels (10 U/ml) of the inflammatory cytokines IL-1β and IFNγ or overnight treatment with the saturated fatty acid palmitate (500 µM) (Figure 2), both of which have been previously shown to trigger ER stress in beta cells (34-36). Cells were also treated for 8 h with thapsigargin, which is a potent ER stress inducing agent (37) (Figure 2). We monitored ER stress by nuclear translocation of CHOP, a multifunctional transcription factor in the ER stress response (Figure 2).\nThe different treatment conditions resulted in varying degrees of ER stress as shown by\nthe timeframe until nuclear translocation of CHOP, indicating that the different treatment conditions affected the cells with variable strength and specificity. While incubation with thapsigargin or palmitate induced CHOP activation at 8 and 18 h respectively, CHOP activation was detected at 48 h (but not 24 h) of cytokine treatment (Figure 2). Notably, all three treatment conditions resulted in a marked increase in the Golgi-localization of GAD65 (Figure 2). Accumulation of GAD65 in Golgi membranes during palmitate induced ER stress was also\nobserved in primary human beta cells and in another cell type expressing GAD65, primary rat hippocampal GABA-ergic neurons (Supplementary Figure 1).\nAccumulation of GAD65 in the Golgi compartment during induction of ER stress by\neither palmitate or thapsigargin was confirmed by co-staining for the Golgi marker giantin (Figure 3A, Supplementary Figure 1A-C) but Golgi structures are also clearly identifiable by GAD65 localization in both beta cells and neurons (12; 15; 38). Quantification following a two hour incubation with either palmitate or thapsigargin revealed a significant accumulation of GAD65 in the Golgi compartment (Figure 3B, Supplementary Figure 1D).\nThe time course of accumulation of GAD65 in Golgi membranes during palmitate\ninduced ER stress was studied further. Rat islet cell monolayers were treated with 100 µM or 500 µM of palmitate for 10 min, 2 h, and 18 h and immunostained for CHOP, GAD65, and insulin (Figure 4, Supplementary Figure 2). Golgi accumulation of GAD65 occurred almost immediately upon addition of palmitate and was clearly visible at 10 min (Figure 4A, Supplementary Figure 2A). The strong Golgi accumulation of GAD65 persisted at 2 h and was still visible at 18 h, although the intensity began to fade coinciding with activation of CHOP (Figure 4C,D). Quantification of GAD65 membrane accumulation showed a statistically significant increase in the ratio of MFI for GAD65 in the Golgi compartment for cells incubated for 10 min and 2 h in 100 or 500 µM palmitate (Figure 4B). Across all conditions and time points there were no notable changes in the subcellular localization of insulin (Supplementary Figure 2B). Taken together the results indicate that induction of ER stress results in aberrant accumulation of GAD65 in the Golgi compartment.\nPalmitoylation is required for GAD65 accumulation in the Golgi compartment during ER\nstress\nThe distribution of GAD65 between ER/cis-Golgi and TGN/vesicular membranes is\ncontrolled by its palmitoylation/depalmitoylation/repalmitoylation cycle. While palmitoylation of cysteines 30 and 45 is not required for firm anchoring of GAD65 to Golgi membranes, it is critical for its anterograde trafficking from cis-Golgi to TGN membranes and targeting to postGolgi vesicles (12). We assessed whether a palmitoylation-deficient mutant of GAD65 was capable of accumulating in the Golgi compartment in beta cells undergoing ER stress. Primary rat beta cells were transfected with either wild-type (WT) GAD65-GFP or palmitoylation deficient GAD65(C30,45A)-GFP, and treated with palmitate or thapsigargin for 1 h to induce ER stress. Cells were imaged live by confocal microscopy and the images were measured for MFI of GAD65-GFP in the Golgi compartment (Figure 5). ER stress induced by palmitate or thapsigargin significantly increased the fraction of WT GAD65-GFP in Golgi and vesicle membranes, while palmitoylation-deficient GAD65(C30,45)-GFP was unaffected (Figure 5). Thus, Golgi accumulation of GAD65 in response to ER stress is restricted to palmitoylation competent GAD65.\nRecovery of wild-type but not palmitoylation-deficient GAD65 in the Golgi compartment\nafter photobleaching is inhibited during ER stress\nWe next assessed the effect of ER stress on the kinetics of replenishment of WT GAD65-\nGFP as well as the palmitoylation deficient mutant GAD65(C30,45A)-GFP into Golgi membranes following irreversible photobleaching. We previously reported that the fluorescence recovery after photobleaching (FRAP) of WT GAD65-GFP in Golgi membranes involves two\npools of the protein, a rapid pool and a slow pool (12). The rapid Golgi replenishment pool represents the non-palmitoylated form of GAD65, which has undergone the first step of hydrophobic modifications resulting in weak on/off membrane association. The second and slower replenishment pool represents palmitoylation competent GAD65, which, following anterograde vesicular trafficking to the TGN and periphery, can undergo depalmitoylation and non-vesicular retrograde trafficking back to Golgi membranes. INS-1E cells (Figure 6A-D) and primary rat islet cells (Supplementary Figures 3,4) were subjected to irreversible photobleaching of the Golgi compartment. Recovery of GAD65-GFP in Golgi membranes was recorded for untreated cells and for cells pre-treated with palmitate (Figure 6, Supplementary Figure 3) or thapsigargin (Supplementary Figure 4) for 1 hour to induce early-stage ER stress. Analysis of the data was performed using non-linear regression, assuming one or multiple pools of replenishing protein. Induction of ER stress significantly impaired the Golgi replenishment kinetics of WT GAD65-GFP in INS-1E cells treated with palmitate (Figure 6C,D) and in primary islet cells treated with either palmitate (Supplementary Figure 3) or thapsigargin (Supplementary Figure 4). In contrast, the Golgi replenishment kinetics of palmitoylation deficient GAD65(C30,45A)-GFP was similar for both untreated and treated cells (Figure 6C,D, Supplementary Figures 3,4). Calculations of half time of recovery of the rapid and slow pools of WT GAD65-GFP, revealed that while the half time of recovery of the rapid pool replenishing the Golgi was minimally or not affected, the half time of recovery of the slow pool was increased 3-4 fold (Figure 6C,D, Supplementary Figures 3,4). The results of these experiments indicate that ER stress, whether induced by palmitate or thapsigargin, inhibits and perturbs the palmitoylation cycle of WT GAD65-GFP.\nUptake and processing of GAD65 by antigen presenting B lymphocytes is enhanced by\npalmitoylation\nGiven that modification of peptides and proteins by palmitoylation may enhance their\nimmunogenicity (39), we assessed whether the palmitoylation state of GAD65 has an effect on its uptake by antigen presenting cells (APCs) and/or activation of T cells in an APC / T-cell coculture assay. Recombinant human GAD65 produced in yeast was depalmitoylated by thiol-acyl cleavage with hydroxylamine (HA), and depalmitoylation was confirmed biochemically by the S-acylation resin-assisted capture (Acyl-RAC) assay (33) (Figure 7A). Analyses of uptake of DyLight-488 labeled palmitoylated and non-palmitoylated GAD65 by the HLA-DR4 (DRB1*0401) positive human B-cell line Priess revealed a 2.5 fold increase in uptake of palmitoylated compared to the de-palmitoylated GAD65 (Figure 7B). Furthermore, Priess cells were loaded with palmitoylated or depalmitoylated GAD65 and used as APCs to stimulate the GAD65 specific HLA-DR4 (DRB1*0401)-restricted murine T-cell hybridoma line T33.1 that recognizes the GAD65274-286 epitope. In this APC / T cell co-culture assay, presentation of palmitoylated GAD65 induced a 3-fold higher secretion of IL-2 by T33.1 cells compared to the depalmitoylated protein (Figure 7C). Taken together, the results indicate that palmitoylation facilitates uptake and processing of GAD65 by APCs resulting in increased antigen-specific stimulation of T cells. Thus the palmitoylated form of GAD65 that accumulates in Golgi during ER stress has higher immunogenicity, consistent with a possible role of ER stress in activating autoreactive T cells in T1D.\nGAD65 accumulates in the Golgi compartment in human beta cells during progression of"
    }, {
      "heading" : "T1D autoimmunity",
      "text" : "We addressed the question whether the experimental accumulation of GAD65 in the\nGolgi compartment induced by treatment with ER stressors in vitro is of relevance for human diabetes. Human pancreatic sections provided by the nPOD tissue bank (28; 29) representing 8 healthy donors (Supplementary Table 1), 8 potentially prediabetic individuals positive for GAD65 autoantibodies (GADA+) (Supplementary Table 2), and 8 T1D patients with residual beta cell mass (Supplementary Table 3) were immunostained for GAD65, giantin, insulin, glucagon and the pan-T cell marker CD3 (Figure 8A-D). In five of eight GADA+ individuals and seven of eight T1D patients, the GAD65 signal in beta cell Golgi membranes compared to cytosol was higher than one standard deviation above the mean for healthy control individuals where GAD65 immunostaining was mostly uniform (Figure 8E, Supplementary Tables 1-3, last column). Staining of serial sections for the pan-T cell marker, CD3 (Figure 8A), confirmed periand intra-islet infiltrating T cells in islets from three of eight GADA+ individuals as well as in six of eight T1D patients (Figure 8A and results not shown). Examination of the nPOD-provided patient information (Supplementary Tables 1-3) for individual donors revealed that the highest Golgi accumulation observed in the pre-diabetic GADA+ group was from a single autoantibody positive (GADA+) 2.2-year-old child expressing the HLA-class II T1D susceptibility haplotype DR4, DQ8 (Supplementary Table 2) showing infiltrates of CD3-positive T cells in and around islets (Figure 8A, nPOD 6090) but not meeting the nPOD insulitis criteria (Supplementary Table 2). This child may represent a case of a young, genetically susceptible individual in the early stages of autoimmunity associated with development of T1D. The lowest Golgi accumulation in the GADA+ group was observed in a 31-year-old, single autoantibody positive (GADA+)\nindividual with normal islet morphology and no insulitis (Supplementary Table 2, nPOD 6181). The highest Golgi accumulation observed in the T1D group was observed in a double autoantibody positive (GADA+ and mIAA+) 11-year-old individual expressing the T1D HLAclass II susceptibility haplotypes DR3, DQ2 and DR4, DQ8 and with ongoing insulitis (Supplementary Table 3) (30) as confirmed by our CD3 immunostaining (Figure 8A, nPOD 6265). Taken together, the results suggest that aberrant accumulation of GAD65 in Golgi membranes may correlate with active islet autoimmunity in human T1D."
    }, {
      "heading" : "DISCUSSION",
      "text" : "Accumulation of GAD65 in Golgi membranes in beta cells experiencing ER stress and/or\nactive autoimmunity\nIn this study, we show that treatment of islet cell cultures by three separate regimens\nknown to induce ER stress in beta cells results in accumulation of GAD65 in Golgi membranes. Importantly, analysis of human pancreatic tissue sections revealed significant accumulation of GAD65 in beta cell Golgi membranes in GADA+ potentially pre-diabetic individuals and in T1D patients with residual beta cell mass. Thus, aberrant accumulation of GAD65 in Golgi membranes is observed both in beta cells in culture undergoing experimentally-induced ER stress as well as in beta cells of individuals experiencing active beta cell autoimmunity.\nGAD65 in pancreatic beta cells undergoes a palmitoylation / depalmitoylation /\nrepalmitoylation cycle, which is perturbed during ER stress resulting in accumulation of\nthe protein in Golgi membranes\nWe have shown earlier that palmitoylation of GAD65 results in anterograde trafficking\nfrom cis-Golgi to TGN membranes (12). The evidence presented in this study shows that only WT GAD65 but not palmitoylation deficient GAD65(C30,45A) accumulates in Golgi membranes during ER stress. This increase of GAD65 in Golgi membranes is consistent with the accumulated protein representing the palmitoylated form of GAD65 in TGN membranes, suggesting that the palmitoylation cycle of GAD65 significantly slows down during induction of ER stress. This retardation in transport likely affects the control of GAD65 distribution between peripheral vesicle membranes, where the majority of GAD65 enzymatic functional activity is\nbelieved to take place, and Golgi membranes, which may serve as a sorting station for this protein. We therefore propose that perturbation in the regulation GAD65 membrane distribution by ER stress may have negative consequences for GABA synthesis and secretion. GABA serves as an important signaling molecule and survival/growth factor in islets of Langerhans (40).\nThe mechanisms by which cytokines, palmitate, and thapsigargin induce ER stress in beta\ncells may differ (34). One commonality between the three different treatments is that each is implicated in dysregulation of calcium homeostasis (41). Both inflammatory cytokines and thapsigargin have been shown to induce beta cell ER stress through downregulation or inhibition of the sarco/endoplasmic reticulum Ca2+ ATPase, resulting in elevation of cytosolic calcium concentrations and depletion of ER Ca2+ stores (42). Palmitate is reported to induce ER stress through lipotoxic signaling pathways mediating a block in ER uptake of Ca2+ and a sustained depletion of ER Ca2+ stores (35; 43). The idea that dysregulation of ER/cytosolic Ca2+ concentrations is involved in Golgi accumulation of GAD65 is supported by the fact that a similar effect could be achieved by strongly depolarizing cells by abruptly elevating extracellular glucose or KCl concentration (Phelps, Cianciaruso, and Baekkeskov unpublished results). While it is currently unknown how a change in calcium homeostasis could affect membrane trafficking of GAD65, it is of note that earlier studies have suggested modulation of the affinity of GAD65 to liposome membranes by calcium ion concentration (44). Interestingly, there is evidence to suggest that palmitate treatment of insulinoma cells alters the lipid composition of endomembranes and specifically disrupts lipid raft microdomains (45), a dynamic hub for palmitoylated proteins (46). It is of note that distribution of H-Ras into lipid rafts is regulated by its palmitoylation/depalmitoylation cycle (47), which shares similarities with the acylation cycle of GAD65 (16). Thus, it is possible that alterations in lipid raft composition are part of the\nmechanism involved in perturbation of GAD65 trafficking and accumulation in Golgi membranes.\nAccumulation of palmitoylated GAD65 in Golgi membranes may have implications for\ninitiation of autoimmunity\nParallel to the important role of GAD65 as the highly regulated and the only GABA\nsynthesizing enzyme in human beta cells, it can assume a detrimental role as a major target of autoimmunity associated with pancreatic human beta cell destruction and development of T1D in genetically susceptible individuals (2). The autoantigenicity of GAD65 is in stark contrast to the highly homologous GAD67 isoform, which is not an independent autoantigen. GAD67 primarily differs from GAD65 in the N-terminal domain (48) that mediates hydrophobic post-translational modifications, membrane anchoring, palmitoylation and trafficking of GAD65 (12), suggesting that this region is integral to the susceptibility of GAD65 to become a pathogenic auto-antigen. GAD67 does not undergo hydrophobic modifications (49) and can only be targeted to membranes by piggy-backing onto other proteins (15; 38).\nOur data show that compared to depalmitoylated GAD65, palmitoylated GAD65 induces\na significantly stronger effector T-cell response by the T cell hybridoma T33.1, which recognizes GAD65274-286 in the context of DR4, a T1D MHC-class II susceptibility haplotype. Palmitoylation of peptide epitopes has been shown to enhance immunogenicity of autoimmune epitopes in experimental autoimmune encephalomyelitis (50) and in synthetic peptide vaccines (51). Palmitoylation of a protein increases its avidity for binding to membranes. The uptake of palmitoylated GAD65 by the DR4-positive human B-cell line Priess was significantly enhanced compared to non-palmitoylated GAD65. We posit that the increase in uptake, conferred by palmitoylation, may involve enhanced binding to the surface of Priess cells resulting in increased\nuptake by endocytosis and enhanced targeting to late endosomes for proteolytic processing and presentation to T cells in the context of MHC-class II antigens (reviewed in (52)). Palmitoylation of GAD65 may also affect antigen unfolding and proteolysis and alter the hierarchy of peptides displayed to CD4+ T cells. The T33.1 hybridoma reporter cell line is clonally restricted to a single MHC-class II binding epitope, GAD65274-286, which is distant from the palmitoylated cysteine residues in GAD65, aa 30 and 45. Therefore, the possibility of palmitoylation increasing the MHC-class II binding affinity of this epitope can be excluded in our experimental system. Rather, we suggest that increased stimulation of T33.1 cells reflects a quantitative increase in the levels of the GAD65274-286 epitope available for binding to DR4 in late endosomes and elevated expression on the surface of Priess cells. If palmitoylated GAD65, which has accumulated in TGN during ER stress, is released by distressed or dying beta cells and encountered by APCs, its heightened immunogenicity compared to non-palmitoylated GAD65 may stimulate autoimmunity in genetically predisposed individuals. An important agenda for future studies will be to elucidate the mechanisms by which palmitoylated, immunogenic GAD65 is released from beta cells undergoing ER stress, as well as the determinants of that stress, which the results presented herein suggest could be key factors in the mechanism that results in autoimmunity to GAD65 associated with development of type I diabetes."
    }, {
      "heading" : "ACKNOWLEDGEMENTS",
      "text" : "We thank Drs. Lorenzo Piemonti, San Raffaele Scientific Research Institute, Milan and\nDomenico Bosco and Thierry Berney, University of Geneva for help in procuring human islets, Gisou van der Goot and Laurence Abrami, EPFL for insightful suggestions and donation of reagents, Janice Blum of Indiana University (Priess cells, T33.1 cells), Linda Wicker of Cambridge Institute for Medical Research, UK (T33.1 cells), Christiana Hämpe of University of Washington, Seattle (N-GAD65 mAb), David Gottlieb, Washington University, Saint Louis (GAD6 antibody), Pierre Maechler of University of Geneva, Switzerland (INS-1E cells), for generously donating cells and reagents."
    }, {
      "heading" : "Funding",
      "text" : "This study was supported by the Intramural Research Program of EPFLs School of Life\nSciences (S.B., J.A.H.), by the Nora Eccles Treadwell Foundation (S.B., J.K.), by an International Network Program from the Danish Ministry of Science, Innovation and Higher Education (INP-2010-0102) (N.B., S.B.) by a JDRF award (31-2008-416) to the European Consortium for Islet Transplantation (ECIT) Islets for Basic Research Program, by a Whitaker International Program Postdoctoral Scholarship (E.A.P.), by a JDRF Advanced Postdoctoral Fellowship (3-APF-2014-208-A-N) (E.A.P.), by the EPFL Bioimaging and Optics Core Facility and EPFL Flow Cytometry Core Facility, by a National Institute of Health Diabetes Education and Research Center grant (P30 DK063720) funded UCSF Diabetes Center Microscopy Core and by the Network for Pancreatic Organ Donors with Diabetes (nPOD), a collaborative T1D research project sponsored by JDRF. Organ Procurement Organizations partnering with nPOD to provide research resources are listed at www.jdrfnpod.org/our-partners.php."
    }, {
      "heading" : "Duality of Interest",
      "text" : "No potential conflicts of interest relevant to this article were reported."
    }, {
      "heading" : "Author contributions",
      "text" : "E.A.P., C.C., J.K., and S.B. developed the concept. E.A.P., C.C., and S.B. designed the\nstudy and analyzed data. E.A.P., C.C., and M.P. conducted all experiments and collected data. J.K. and N.B. assisted with developing primary beta cell single cell culture and transfection techniques. I.A.M. contributed critical reagents, technical expertise, and assisted in experiments related to GAD65-GFP expression. J.A.H. contributed critical reagents and expertise. R.N. and V.L. isolated the human islets provided through the ECIT islet distribution network. E.A.P. and S.B. wrote the manuscript with input from the other authors. S.B. is the guarantor of this work and, as such, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis."
    }, {
      "heading" : "Prior Presentation",
      "text" : "Part of this work was presented at the Biomedical Engineering Society Annual Scientific Meeting, Tampa, Florida, USA, 7-10 October, 2015; and the Keystone Symposia, Islet Biology: From Cell Birth to Death, Keystone CO, USA, 13-17 March, 2016."
    }, {
      "heading" : "FIGURE LEGENDS",
      "text" : "Figure 1. Confocal analyses of GAD65 localization in primary beta cells. (A) Primary rat beta cells immunostained for GAD65 and giantin (Golgi) show a subcellular distribution of GAD65 in the cytosol and the Golgi compartment. Apart from the Golgi compartment, GAD65 is localized to vesicles, which are distinct from insulin granules. The confocal images are representative of similar analyses of 7 independent isolations of rat islets. Scale bar 10 µm. (B) Immunostaining of primary human beta cells for GAD65, giantin, and insulin reveals localization of GAD65 in the Golgi compartment as well as in peripheral vesicles distinct from insulin containing vesicles. The confocal images are representative of similar analyses of independent isolations of human islets from 4 donors. Scale bar 10 µm.\nFigure 2. Activation of ER stress pathways in beta cells by thapsigargin, palmitate, or inflammatory cytokines. Primary rat beta cells were treated with palmitate (500 µM, 18 h), thapsigargin (2 µM, 8 h), or cytokines (10 U/ml, 8, 24, or 48 h) to induce ER stress and immunostained for GAD65 (top two panels) and CHOP (bottom panel). GAD65 positive Golgi compartments are indicated by arrowheads. For all three treatment modules, GAD65 expression in the Golgi compartment becomes noticeably brighter. Middle panels show increased magnification of framed regions in the top panels. The confocal images are representative of similar analyses of 6 independent isolations of rat islets. Scale bars 10 µm.\nFigure 3. Treatment of beta cells with palmitate or thapsigargin promotes Golgi accumulation of GAD65. (A) Primary rat beta cells were treated with palmitate (500 µM, 2 h) or thapsigargin (2\nµM, 2 h) to induce ER stress and immunostained for GAD65 and Giantin. (B) Image quantification of GAD65 accumulation in the Golgi compartment reported as the ratio of MFI for GAD65 in the Golgi compartment and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell excluding the nucleus. Results are presented as mean ± SEM (n = 39-43 beta cells from 8 image fields analyzed per condition. Cells positive for giantin and negative for GAD65 represent non-beta islet cells). Data were analyzed using one-way ANOVA followed by Tukey’s multiple comparisons test (** P < 0.001). Analyses of accumulation of GAD65 in Golgi membranes in rat beta cells, human beta cells, and rat hippocampal neurons incubated with palmitate for 2 h is shown in Supplementary Figure 1.\nFigure 4. Time course of Golgi accumulation of GAD65 upon palmitate treatment. (A) Confocal analyses of monolayer cultures of primary rat beta cells treated or not with 100 µM palmitate, or 500 µM palmitate for 10 min, 2 h, and 18 h respectively. Fixed cells were immunostained for GAD65 and CHOP. Scale bar 10 µm. (B) Image quantification of GAD65 accumulation in the Golgi compartment reported as the ratio of MFI for GAD65 in the Golgi and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell excluding the nucleus. Results are presented as mean ± SEM (n = 28-45 cells from 4-5 image fields analyzed per condition). Data were analyzed using two-way ANOVA followed by Tukey’s multiple comparisons test (* P < 0.05, ** P < 0.01 and *** P < 0.001). (C) Image quantification of CHOP positive nuclei as a percentage of total nuclei. Results are presented as mean ± SEM (n = 4-10 image fields analyzed per condition). Data were analyzed using two-way ANOVA followed by Tukey’s multiple comparisons test (* P < 0.05, ** P < 0.01 and *** P < 0.001). Corresponding lower magnification images of primary beta rat beta cells stained for GAD65 and insulin are shown in Supplementary Figure 2.\nFigure 5. Palmitoylation is required for Golgi accumulation of GAD65. (A) Primary rat beta cells were transfected with either WT GAD65-GFP or the palmitoylation deficient mutant GAD65(C30,45A)-GFP and imaged live following a 1 h treatment with palmitate (500 µM) or thapsigargin (2 µM) to induce ER stress. Images are also displayed with a heat-map to highlight the increase in Golgi and vesicle brightness. Golgi regions are indicated with a dashed outline. Scale bar 10 µm. (B) Image quantification of GAD65 accumulation in the Golgi compartment expressed as the ratio of MFI for GAD65 in the Golgi and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell excluding the nucleus. Results are presented as mean ± SEM (n = 6-10 cells analyzed per condition). Data were analyzed using one-way ANOVA followed by Tukey’s multiple comparisons test (* P < 0.05).\nFigure 6. Fluorescence recovery after photobleaching in the Golgi of WT but not palmitoylationdeficient GAD65 is inhibited during ER stress. (A) Live cell images of INS-1E cells transfected with GAD65-GFP before and after treatment with palmitate (500 µM) for 1 h show accumulation of GAD65-GFP in the Golgi. Scale bar 10 µm. (B) Representative images from FRAP analyses of INS-1E cells expressing either WT GAD65-GFP or palmitoylation-deficient GAD65(C30,45A)-GFP. The entire Golgi compartment was photobleached and recovery of fluorescence was followed by live cell imaging. Scale bar 10 µm. (C) Kinetics of fluorescence recovery after bleaching the entire Golgi-associated pool of WT GAD65-GFP or GAD65(C30,45A) in INS-1E cells pretreated or not with palmitate for 1 h. Results from a representative experiment are presented as mean ± SEM (n = 10 cells per condition). (D) Calculated halftimes of Golgi fluorescence recovery in INS-1E cells following photobleaching.\nWT GAD65-GFP exhibits two-phase recovery kinetics corresponding to a rapid as well as a slow recovery pool, while palmitoylation-deficient GAD65(C30,45A)-GFP exhibits single-phase recovery kinetics corresponding to a rapid recovery pool. Results are presented as the mean halftime of recovery ± SEM (n = 3 independent experiments, 10 cells per experiment). Data were analyzed by Student’s t-test comparing the halftime parameter between the association curve fits of the combined data set from three independent experiments (*** P < .001). FRAP analyses of GAD65 Golgi recovery in primary rat beta cells treated with palmitate or thapsigargin are shown in Supplementary Figure 3 and Supplementary Figure 4, respectively.\nFigure 7. Palmitoylation confers increased immunogenicity upon GAD65. (A) Recombinant human GAD65 produced in yeast was shown to be palmitoylated by the S-acylation resinassisted capture (Acyl-RAC) assay. Free thiols in recombinant GAD65 were capped with methyl methanethiosulfonate (MMTS) followed by cleavage of palmitate-thiol modifications with hydroxylamine (HA), pulldown with a thiol-reactive pyridyl-disulfide agarose resin, and detection by Western blot. Lanes: i =input, positive control of unmodified recombinant GAD65; -HA = negative control without HA resulting in no palmitate cleavage and no protein pulldown; +HA = HA added with palmitate groups cleaved and protein recovered by thiol-reactive pulldown. (B) Time course of uptake of equimolar amounts of DyLight-488 labeled palmitoylated or depalmitoylated (HA cleaved) recombinant GAD65 by MHC-class II DR4 positive human Priess B-cell APCs measured by flow cytometry. Results are presented as mean ± SEM (n = 3 experimental replicates). Data were analyzed by two-way ANOVA followed by Tukey’s multiple comparisons test (*** P < 0.001). (C) Priess cells were loaded with equimolar amounts of palmitoylated or depalmitoylated GAD65 (HA cleaved) and tested for stimulation of\nthe DR4 restricted GAD65-specific T33.1 T-cell hybridoma cells by IL-2 secretion measured by ELISA. Results are presented as mean ± SEM (n = 3 experimental replicates). Data were analyzed by two-way ANOVA followed by Tukey’s multiple comparisons test (*** P < 0.001).\nFigure 8. Confocal analyses of islets in paraffin sections of human pancreas from healthy, nondiabetic GAD65 autoantibody positive, or T1D with residual beta cell mass. (A) Immunostaining of human pancreatic sections for insulin, glucagon or CD3 from the indicated nPOD case numbers. Arrowheads indicate CD3+ T-cells. Scale bar 50 µm. (B) The same human islet from a serial section, immunostained for GAD65 and giantin. Scale bar 50 µm. (C) Increased magnification of GAD65 staining in the framed region shown in (B). Scale bar 10 µm. (D) Thresholded binary images of the same region in (C) show the colocalization between giantin (Golgi) and the bright GAD65 signal. Scale bar 10 µm. (E) Image quantification of GAD65 accumulation in the Golgi compartment in 3 representative islets from 8 individuals per donor category, reported as the ratio of MFI for GAD65 in the Golgi of beta cells to MFI for GAD65 in the rest of the cell excluding the nucleus. Results are presented as scatter dot plots overlaying the mean ± SEM (n = 24 islets from 8 donors). Data were analyzed by one-way ANOVA followed by Tukey’s multiple comparisons test (* P < 0.05, ** P < 0.01). The average GAD65 Golgi accumulation calculated per individual as well as demographic information for healthy, GADA+, and T1D donors is listed in Supplementary Tables 1-3.\nG A\nD 65\nG ia\nnt in\nD A\nP I\nUntreated Palmitate Thapsigargin\nG ia\nnt in\nD A\nP I\nG A\nD 65\nD A\nP I\nD A\nP I\nGAD65 Golgi accumulation\nM FI\nra tio\nG ol\ngi +\nve si\ncl es\n:c yt\nos ol\nUn tre\nate d\nPa lm\nita te\nTh ap\nsig arg\nin 1.0\n1.5\n2.0\n2.5\n3.0 ***\n***\nA\nB Figure 3. Treatment of beta cells with palmitate or thapsigargin promotes Golgi accumulation of GAD65. (A) Primary rat beta cells were treated with palmitate (500 µM, 2 h) or thapsigargin (2 µM, 2 h) to induce ER\nstress and immunostained for GAD65 and Giantin. (B) Image quantification of GAD65 accumulation in the Golgi compartment reported as the ratio of MFI for GAD65 in the Golgi compartment and GAD65positive vesicles to MFI for GAD65 in the rest of the cell excluding the nucleus. Results are presented as mean ± SEM (n = 39-43 beta cells from 8 image fields analyzed per condition. Cells positive for giantin and negative for GAD65 represent non-beta islet cells). Data were analyzed using one-way ANOVA followed by Tukey’s multiple comparisons test (** P < 0.001). Analyses of accumulation of GAD65 in Golgi membranes in rat beta cells, human beta cells, and rat hippocampal neurons incubated with palmitate for 2 h is shown in Supplementary Figure 1.\nGAD65 10 m in\n2 h\n18 h\nuntreated 100 µM palmitate 500 µM palmitate\nCHOP\n10 m in 2\nh 18 h\nuntreated 100 µM palmitate 500 µM palmitate\nDAPI\nC\nA B\nD\nGAD65 Golgi accumulation\nM FI\nra tio\nG ol\ngi +\nve si\ncl es\n:c yt\nos ol\n10 min 2 hr 18 hr 1.0\n1.5\n2.0\n2.5\n3.0\n3.5\nuntreated 100 µM palmitate 500 µM palmitate\n***\n***\n**\nns * *\nCHOP activation P er ce nt ag e C H O P po si tiv e ce lls\n10 min 2 hr 18 hr 0%\n20%\n40%\n60%\n80%\n100% untreated 100 µM palmitate 500 µM palmitate\nns\n**\nns\n**\n***\nns\nFigure 4. Time course of Golgi accumulation of GAD65 upon palmitate treatment. (A) Confocal analyses of monolayer cultures of primary rat beta cells treated or not with 100 µM palmitate, or 500 µM palmitate for 10 min, 2 h, and 18 h respectively. Fixed cells were immunostained for GAD65 and CHOP. Scale bar 10 µm. (B) Image quantification of GAD65 accumulation in the Golgi compartment reported as the ratio of MFI for GAD65 in the Golgi and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell excluding the nucleus. Results are presented as mean ± SEM (n = 28-45 cells from 4-5 image fields analyzed per condition). Data were analyzed using two-way ANOVA followed by Tukey’s multiple comparisons test (* P < 0.05, ** P < 0.01 and *** P < 0.001). (C) Image quantification of CHOP positive nuclei as a percentage of total nuclei. Results are presented as mean ± SEM (n = 4-10 image fields analyzed per condition). Data were analyzed using two-way ANOVA followed by Tukey’s multiple comparisons test (* P < 0.05, ** P < 0.01 and *** P < 0.001). Corresponding lower magnification images of primary beta rat beta cells stained for GAD65 and insulin are shown in Supplementary Figure 2.\nA Bbefore treatment\n+ palmitate (1 hr)\nW T\nG A\nD 65\n-G FP\nG A\nD 65\n(C 30\n,4 5A\n)- G\nFP\ninitial bleach Golgi recovery (180 sec)\nW T\nG A\nD 65\n-G FP\nW T\nG A\nD 65\n-G FP\ninitial bleach Golgi recovery (180 sec)\nC\nD\nWT GAD65-GFP\ntime (sec)\nFr ac\ntio n\nof in\niti al\nflu or\nes ce\nnc e\n0 20 40 60 80 100120140160180 0.0\n0.2\n0.4\n0.6\n0.8\n1.0\n1.2\nuntreated palmitate\nGAD65(C30,45A)-GFP\ntime (sec)\nFr ac\ntio n\nof in\niti al\nflu or\nes ce\nnc e\n0 20 40 60 80 100120140160180 0.0\n0.2\n0.4\n0.6\n0.8\n1.0\n1.2\nuntreated palmitate\nWT GAD65-GFP Two phase kinetics\nH al\nfti m\ne of\nre co\nve ry\n(s ec\n)\nrapid pool slow pool 0\n25\n50 50\n200 350 500 ***\nns\nuntreated palmitate\nGAD65(C30,45A)-GFP Single phase kinetics\nH al\nfti m\ne of\nre co\nve ry\n(s ec\n)\nrapid pool 0\n25\n50 50\n200 350 500 untreated palmitate\nns\nFigure 6. Fluorescence recovery after photobleaching in the Golgi of WT but not palmitoylation-deficient GAD65 is inhibited during ER stress. (A) Live cell images of INS-1E cells transfected with GAD65-GFP before and after treatment with palmitate (500 µM) for 1 h show accumulation of GAD65-GFP in the Golgi. Scale bar 10 µm. (B) Representative images from FRAP analyses of INS-1E cells expressing either WT GAD65-GFP or palmitoylation-deficient GAD65(C30,45A)-GFP. The entire Golgi compartment was photobleached and recovery of fluorescence was followed by live cell imaging. Scale bar 10 µm. (C) Kinetics of fluorescence recovery after bleaching the entire Golgi-associated pool of WT GAD65-GFP or GAD65(C30,45A) in INS-1E cells pretreated or not with palmitate for 1 h. Results from a representative experiment are presented as mean ± SEM (n = 10 cells per condition). (D) Calculated halftimes of Golgi fluorescence recovery in INS-1E cells following photobleaching. WT GAD65-GFP exhibits two-phase recovery kinetics corresponding to a rapid as well as a slow recovery pool, while palmitoylation-deficient GAD65(C30,45A)-GFP exhibits single-phase recovery kinetics corresponding to a rapid recovery pool. Results are presented as the mean halftime of recovery ± SEM (n = 3 independent experiments, 10 cells per experiment). Data were analyzed by Student’s t-test comparing the halftime parameter between the association curve fits of the combined data set from three independent experiments (*** P < .001). FRAP analyses of GAD65 Golgi recovery in primary rat beta cells treated with palmitate or thapsigargin are shown in Supplementary Figure 3 and Supplementary Figure 4, respectively.\nA G A D 65 G A D 65 G ia nt in In su lin G lu ca go n C D 3\nHealthy GADA+ T1D\nnPOD #6282 nPOD #6090 nPOD #6265\nG A\nD 65\nG ia\nnt in\nC ol\noc .\nB\nC\nD\nE\nM FI\nra tio\nG ol\ngi :r\nes to\nfc el\nl\nHe alt\nhy\nGA DA\n+ T1\nD 1.0\n1.5\n2.0\n2.5\n3.0\nHuman Islet GAD65 Golgi Accumulation\n** *\nFigure 8. Confocal analyses of islets in paraffin sections of human pancreas from healthy, non-diabetic GAD65 autoantibody positive, or T1D with residual beta cell mass. (A) Immunostaining of human pancreatic sections for insulin, glucagon or CD3 from the indicated nPOD case numbers. Arrowheads indicate CD3+ T-cells. Scale bar 50 µm. (B) The same human islet from a serial section, immunostained for GAD65 and giantin. Scale bar 50 µm. (C) Increased magnification of GAD65 staining in the framed region shown in (B). Scale bar 10 µm. (D) Thresholded binary images of the same region in (C) show the colocalization between giantin (Golgi) and the bright GAD65 signal. Scale bar 10 µm. (E) Image quantification of GAD65 accumulation in the Golgi compartment in 3 representative islets from 8 individuals per donor category, reported as the ratio of MFI for GAD65 in the Golgi of beta cells to MFI for GAD65 in the rest of the cell excluding the nucleus. Results are presented as scatter dot plots overlaying the mean ± SEM (n = 24 islets from 8 donors). Data were analyzed by one-way ANOVA followed by Tukey’s multiple comparisons test (* P < 0.05, ** P < 0.01). The average GAD65 Golgi accumulation calculated per individual as well as demographic information for healthy, GADA+, and T1D donors is listed in Supplementary Tables 1-3.\nSupplementary Figure 1. Accumulation of GAD65 in Golgi membranes during palmitate\ninduced ER stress in rat and human beta cells and in rat neurons. (A) Rat beta cells, (B) human\nbeta cells, or (C) rat neurons were left untreated or treated with palmitate (500 µM) for 2 h.\nFixed cells were immunostained for GAD65 and giantin (Golgi). Scale bar 10 µm. (D) Image\nquantification of GAD65 accumulation in the Golgi compartment expressed as the ratio of MFI\nfor GAD65 in the Golgi and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell\nexcluding the nucleus. Results are presented as mean ± SEM (n = 30-63 cells analyzed per\ncondition for rat beta cells, n = 24-38 cells analyzed per condition for human beta cells, n = 15-\n17 cells analyzed per condition for rat neurons). Data were analyzed using Student’s t-test (*** P\n< 0.001).\nSupplementary Figure 2. Time course of Golgi accumulation of GAD65 upon palmitate\ntreatment. Confocal analyses of monolayer cultures of primary rat beta cells left untreated or\ntreated with 100 µM palmitate or 500 µM palmitate for 10 min, 2 h, and 18 h respectively. Fixed\ncells were immunostained for GAD65, insulin, and CHOP. Staining for CHOP and higher\nmagnification GAD65 images of the framed regions in the left panel are shown in Figure 4."
    }, {
      "heading" : "Scale bars 10 µm.",
      "text" : "Supplementary Figure 3. Fluorescence recovery after photobleaching in the Golgi of WT but\nnot palmitoylation-deficient GAD65 is inhibited during palmitate-induced ER stress. (A)\nKinetics of fluorescence recovery after bleaching the entire Golgi-associated pool of WT\nGAD65-GFP or GAD65(C30,45A) in primary rat beta cells pretreated or not with palmitate (500\nµM) for 1 h. Results are presented as mean ± SEM (n = 9-15 cells per condition). (B) Halftimes\nof Golgi fluorescence recovery in primary rat beta cells. Results are presented as the mean ±\nSEM (n = 9-15 cells per condition). Data were analyzed by Student’s t-test comparing the\nhalftime parameter between association curve fits (* P < 0.05, *** P < 0.001).\nSupplementary Figure 4. Fluorescence recovery after photobleaching in the Golgi of WT but\nnot palmitoylation-deficient GAD65 is inhibited during thapsigargin-induced ER stress. (A)\nKinetics of fluorescence recovery after bleaching the entire Golgi-associated pool of WT\nGAD65-GFP or GAD65(C30,45A) in primary rat beta cells pretreated or not with thapsigargin\n(2 µM) for 1 h. Results are presented as mean ± SEM (n = 6-10 cells per condition). (B)\nHalftimes of Golgi fluorescence recovery in primary rat beta cells. Results are presented as the\nmean ± SEM (n = 6-10 cells per condition). Data were analyzed by Student’s t-test comparing\nthe halftime parameter between association curve fits (* P < 0.05, *** P < 0.001).\nSupplementary Table 1. Demographic and patient information for JDRF nPOD human\npancreatic sections from non-diabetic donors. Donor information obtained from the nPOD online\npathology database. Data shown in the last column are from this study.\nSupplementary Table 2. Demographic and patient information for JDRF nPOD human\npancreatic sections from GADA+ donors who have not yet progressed to clinical type 1 diabetes.\nDonor information obtained from the nPOD online pathology database. Data shown in the last\ncolumn are from this study.\nSupplementary Table 3. Demographic and patient information for JDRF nPOD human\npancreatic sections from type 1 diabetic donors. Donor information obtained from the nPOD\nonline pathology database. Data shown in the last column are from this study.\nA untreated palmitate Rat beta cells Human beta cells\nRat neurons\nG A\nD 65\nG ia\nnt in\nG A\nD 65\nG ia\nnt in\nB\nC D\nuntreated palmitate\nuntreated palmitate\nG A\nD 65\nG ia\nnt in\nO ve\nrla y\nO ve\nrla y\nO ve\nrla y\nGAD65 Golgi Accumulation\nM FI\nra tio\nG ol\ngi +\nve si\ncl es\n:c yt\nos ol\nrat beta hu beta rat neuron 1.0\n1.5\n2.0\n2.5\n3.0\n3.5\n4.0\n4.5\n5.0 BSA palmitate\n*** ***\n***\nSupplementary Figure 1. Accumulation of GAD65 in Golgi membranes during palmitate induced ER stress in rat and human beta cells and in rat neurons. (A) Rat beta cells, (B) human beta cells, or (C) rat neurons were left untreated or treated with palmitate (500 µM) for 2 h. Fixed cells were immunostained for GAD65 and giantin (Golgi). Scale bar 10 µm. (D) Image quantification of GAD65 accumulation in the Golgi compartment expressed as the ratio of MFI for GAD65 in the Golgi and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell excluding the nucleus. Results are presented as mean ± SEM (n = 30-63 cells analyzed per condition for rat beta cells, n = 24-38 cells analyzed per condition for human beta cells, n = 15-17 cells analyzed per condition for rat neurons). Data were analyzed using Student’s t-test (*** P < 0.001).\nGAD65\nuntreated 100 µM palmitate 500 µM palmitate\n10 m in 2\nh 18 h A\nInsulin\n10 m in 2\nh 18 h\nuntreated 100 µM palmitate 500 µM palmitate B\nSupplementary Figure 2. Time course of Golgi accumulation of GAD65 upon palmitate treatment. Confocal analyses of monolayer cultures of primary rat beta cells left untreated or treated with 100 µM palmitate or 500 µM palmitate for 10 min, 2 h, and 18 h respectively. Fixed cells were immunostained for GAD65, insulin, and CHOP. Staining for CHOP and higher magnification GAD65 images of the framed regions in the left panel are shown in Figure 4. Scale bars 10 µm.\nWT GAD65-GFP\ntime (sec)\nFr ac\ntio n\nof in\niti al\nflu or\nes cn\nce\n0 50 100 150 200 250 300 0.0\n0.2\n0.4\n0.6\n0.8\n1.0\n1.2\nuntreated palmitate\nGAD65(C30,45A)-GFP\ntime (sec)\nFr ac\ntio n\nof in\niti al\nflu or\nes cn\nce\n0 50 100 150 200 250 300 0.0\n0.2\n0.4\n0.6\n0.8\n1.0\n1.2\nuntreated palmitate\nA\nB GAD65(C30,45A)-GFP Single phase kinetics\nH al\nfti m\ne of\nre co\nve ry\n(s ec\n)\nrapid pool 0\n10 20 30 40 50 50\n150 250 350 450\nns\nuntreated palmitate\nWT GAD65-GFP Two phase kinetics\nH al\nfti m\ne of\nre co\nve ry\n(s ec\n)\nrapid pool slow pool 0\n10 20 30 40 50 50\n150 250 350 450 ***\nns\nuntreated palmitate\nSupplementary Figure 3. Fluorescence recovery after photobleaching in the Golgi of WT but not palmitoylation-deficient GAD65 is inhibited during palmitate-induced ER stress. (A) Kinetics of fluorescence recovery after bleaching the entire Golgi-associated pool of WT GAD65-GFP or GAD65(C30,45A) in primary rat beta cells pretreated or not with palmitate (500 µM) for 1 h. Results are presented as mean ± SEM (n = 9-15 cells per condition). (B) Halftimes of Golgi fluorescence recovery in primary rat beta cells. Results are presented as the mean ± SEM (n = 9-15 cells per condition). Data were analyzed by Student’s t-test comparing the halftime parameter between association curve fits (* P < 0.05, *** P < 0.001).\nWT GAD65-GFP\ntime (sec)\nFr ac\ntio n\nof in\niti al\nflu or\nes cn\nce\n0 50 100 150 200 250 300 0.0\n0.2\n0.4\n0.6\n0.8\n1.0\n1.2\nuntreated thapsigargin\nGAD65(C30,45A)-GFP\ntime (sec)\nFr ac\ntio n\nof in\niti al\nflu or\nes cn\nce\n0 50 100 150 200 250 300 0.0\n0.2\n0.4\n0.6\n0.8\n1.0\n1.2\nuntreated thapsigargin\nA\nB GAD65(C30,45A)-GFP Single phase kinetics\nH al\nfti m\ne of\nre co\nve ry\n(s ec\n)\nrapid pool 0\n10 20 30 40 50 50\n150 250 350 450 550\n*\nuntreated thapsigargin\nWT GAD65-GFP Two phase kinetics\nH al\nfti m\ne of\nre co\nve ry\n(s ec\n)\nrapid pool slow pool 0\n10 20 30 40 50 50\n150 250 350 450 550\n***\nns\nuntreated thapsigargin\nSupplementary Figure 4. Fluorescence recovery after photobleaching in the Golgi of WT but not palmitoylation-deficient GAD65 is inhibited during thapsigargin-induced ER stress. (A) Kinetics of fluorescence recovery after bleaching the entire Golgi-associated pool of WT GAD65-GFP or GAD65(C30,45A) in primary rat beta cells pretreated or not with thapsigargin (2 µM) for 1 h. Results are presented as mean ± SEM (n = 6-10 cells per condition). (B) Halftimes of Golgi fluorescence recovery in primary rat beta cells. Results are presented as the mean ± SEM (n = 6-10 cells per condition). Data were analyzed by Student’s t-test comparing the halftime parameter between association curve fits (* P < 0.05, *** P < 0.001).\nnPOD CaseID Donor Type AutoAb\nAge (years) Diabetes Duration (years) Gender Ethnicity\nC-peptide (ng/ml) BMI Cause of Death nPOD histopathology notes HLA\nGolgi : Cell MFI ratio *\n6096 No diabetes Negative 16 n/a Female African American 2.97 18.8 Head Trauma Ins+/Gluc+ normal islets. DRB1*0302,1503 DQA1*0102,0401 DQB1*0402,0602 1.56 6164 No diabetes Negative 0.03 n/a Male Caucasian not provided\n16.5 Anoxia Ins+/Gluc+ normal islets. DRB1*0301,0301 DQA1*0501,0501 DQB1*0201,0201 1.55\n6162 No diabetes Negative 22.7 n/a Male African American 7.61 28.9 Head Trauma Ins+/Gluc+ normal islets. DRB1*1303,1602 DQA1*0102,0501 DQB1*0301,0502 1.45 6289 No diabetes Negative 19 n/a Male African American\n8.05 38.3 Head Trauma Ins+/Gluc+ normal islets. DRB1*0411,0701 DQA1*0201,0301 DQB1*0202,0302 1.44\n6112 No diabetes Negative 6.3 n/a Female Hispanic 5.11 18.4 Head Trauma Ins+/Gluc+ normal islets. DRB1*0407,1302 DQA1-0102,0301 DQB1*0301,0501 1.37 6178 No diabetes\nNegative 24.5 n/a Female Caucasian 4.55 27.5 Anoxia Ins+/Gluc+ normal islets. DRB1*0401,1501 DQA1*0102,0301 DQB1*0301,0602 1.36\n6282 No diabetes Negative 14 n/a Male Caucasian 6.83 41.9 Head Trauma Ins+/Gluc+ normal islets. DRB1*1301,1501 DQA1*0102,0103 DQB1*0602,0603 1.32 6168 No diabetes No serum available 51 n/a Male Hispanic not provided 25.2 Cerebrovascular/ Stroke\nIns+/Gluc+ normal islets. DRB1*0103,0404 DQA1*0101,0301 DQB10302,0501 1.27\n* Cases are arranged from highest to lowest GAD65 MFI ratio for GAD65 in the Golgi compartment to the rest of the cell\nSupplementary Table 1. Demographic and patient information for JDRF nPOD human pancreatic sections from non-diabetic donors. Donor information obtained from the nPOD online pathology database. Data shown in the last column are from this study.\nnPOD CaseID Donor Type AutoAb\nAge (years) Diabetes Duration (years) Gender Ethnicity\nC-peptide (ng/ml) BMI Cause of Death nPOD histopathology notes HLA\nGolgi : Cell MFI ratio *\n6090 Autoab positive GADA+ 2.2 n/a Male Hispanic 5.34 18.8 Head Trauma Ins+/Gluc+ islets, numerous. CD3+ infiltrates throughout exocrine tissue.\nDRB1*0404,1501 DQA1*0102,0301 DQB1*0302,0602 2.11\n6310 Autoab positive GADA+ 28 n/a Female Hispanic 10.54 23.9 Anoxia Ins+/Gluc+ islets, numerous, some hyperplastic. Low grade insulitis, periphery and foci. DR*07,01 1.84 6123 Autoab positive GADA+ 23.2 n/a Female Caucasian 2.01 17.6 Head Trauma Ins+/Gluc+ islets, various sizes.\nDRB1*0801,1101 DQA1*0401,0501 DQB1*0301,0402 1.75\n6314 Autoab positive GADA+ 21 n/a Male Caucasian 1.49 23.8 Head Trauma Ins+/Gluc+ islets, numerous, several large islets (200- 400um). Insulitis not observed.\nDR*03,04 1.59\n6147 Autoab positive GADA+ 23.8 n/a Female Caucasian 3.19 32.9 Head Trauma Ins+/Gluc+ normal islets. DRB1*0301,0401 DQA1*0301,0401 DQB1*0302,0302 1.54 6267 Autoab positive GADA+ IA2A+ 23 n/a Female Caucasian 16.59 23.5 Anoxia Ins+/Gluc+ normal islets. Insulitis found in all regions.\nDRB1*0302,0701 DQA1*0201,0401 DQB1*0202,0402 1.48\n6197 Autoab positive GADA+ IA2A+ 22 n/a Male African American 17.48 28.2 Head Trauma Ins+/Gluc+ islets, plentiful. Insulitis (rare).\nDRB1*0101,0401 DQA1*0201,0401 DQB1*0202,0402 1.41\n6181 Autoab positive GADA+ 31.9 n/a Male Caucasian 0.6 21.9 Head Trauma Ins+/Gluc+ normal islets. DRB1*0101,0401 DQA1*0101,0301 DQB1*0302,0501 1.29\n* Cases are arranged from highest to lowest GAD65 MFI ratio for GAD65 in the Golgi compartment to rest of the cell\nSupplementary Table 2. Demographic and patient information for JDRF nPOD human pancreatic sections from GADA+ donors who have not yet progressed to clinical type 1 diabetes. Donor information obtained from the nPOD online pathology database. Data shown in the last column are from this study.\nnPOD CaseID Donor Type AutoAb\nAge (years) Diabetes Duration (years) Gender Ethnicity\nC-peptide (ng/ml) BMI Cause of Death\nnPOD histopathology notes HLA\nGolgi : Cell MFI ratio *\n6265 T1D GADA+ mIAA+\n11 8 Male Caucasian 0.06 12.9 Cerebrovascular/Stroke Ins+/Gluc+ islets-rare with remainder insulinnegative. Insulitis present. DRB1*0301,0401 DQA1*0301,0401 DQB1*0201,0302 2.28\n6088 T1D GADA+ IA-2A+ ZnT8A+ mIAA+\n31.2 5 Male Caucasian <0.05 27 Head Trauma Ins+/Gluc+ islets (much decreased). Insulitis present.\nDRB1*0101,0301 DQA1*0101,0501 DQB1*0201,0501 1.80\n6245 T1D GADA+ IA-2A+\n22 7 Male Caucasian <0.05 23.2 Head trauma Ins+ (reduced frequency)/Gluc+ islets, some pseudoatrophic (gluc+ only). Possible insulitis.\nDRB1*0301,0405 DQA1*0301,0501 DQB1*0201,0302 1.70\n6211 T1D GADA+ IA-2A+ ZnT8A+ mIAA+\n24 4 Female African American <0.05 24.4 Anoxia Ins+(reduced)/Gluc+ islets, numerous. DRB1*0405,1201 DQA1*0301,0501 DQB1*0301,0302 1.70\n6195 T1D GADA+ IA-2A+ ZnT8A+ mIAA+\n19.2 5 Male Caucasian <0.05 23.7 Head Trauma Ins+ (rare)/Gluc+ islets. Insulitis present in a small number of islets.\nDRB1*0401,1501 DQA1*0102,0301 DQB1*0302,0602 1.58\n6046 T1D IA-2A+ ZnT8A+\n18.8 8 Female Caucasian <0.05 25.2 Anoxia Ins+/Gluc+ islets in occ. lobule, other lobules/entire blocks ins-/gluc+ islets. Insulitis present. DRB1*0101,0401 DQA1*0101,0301 DQB1*0302,0501 1.55\n6084 T1D mIAA+ 14.2 4 Male Caucasian <0.05 26.3 Anoxia Ins+/Gluc+ islets in lobules with moderate to severe adipose infiltrates. Very irregular islets. DRB1*0301,0401 DQA1*0301,0501 DQB1*0201,0302 1.53 6049 T1D GADA+ mIAA+ 15 10 Female African American <0.05 20.8 Anoxia Ins-/Gluc+ (majority) islets with rare Ins+ islets.\nDRB1*0404,0901 DQA1*0301,0301 DQB1*0201,0302 1.44\n* Cases are arranged from highest to lowest GAD65 MFI ratio for GAD65 in the Golgi compartment to rest of the cell\nSupplementary Table 3. Demographic and patient information for JDRF nPOD human pancreatic sections from type 1 diabetic donors. Donor information obtained from the nPOD online pathology database. Data shown in the last column are from this study."
    } ],
    "references" : [ {
      "title" : "Two genes encode distinct glutamate decarboxylases",
      "author" : [ "MG Erlander", "NJK Tillakaratne", "S Feldblum", "N Patel", "AJ. Tobin" ],
      "venue" : "Neuron",
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 1991
    }, {
      "title" : "Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase",
      "author" : [ "S Baekkeskov", "HJ Aanstoot", "S Christgau", "A Reetz", "M Solimena", "M Cascalho", "F Folli", "H RichterOlesen", "P. De Camilli" ],
      "venue" : "Nature",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 1990
    }, {
      "title" : "Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes",
      "author" : [ "S Baekkeskov", "M Landin", "JK Kristensen", "S Srikanta", "GJ Bruining", "T Mandrup-Poulsen", "C de Beaufort", "JS Soeldner", "G Eisenbarth", "F Lindgren" ],
      "venue" : "J Clin Invest",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 1987
    }, {
      "title" : "Mr autoantibodies as predictors of insulin-dependent diabetes",
      "author" : [ "MA Atkinson", "NK Maclaren", "DW Scharp", "PE Lacy", "WJ. Riley" ],
      "venue" : null,
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 1990
    }, {
      "title" : "Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets",
      "author" : [ "J Kim", "W Richter", "HJ Aanstoot", "Y Shi", "Q Fu", "R Rajotte", "G Warnock", "S. Baekkeskov" ],
      "venue" : "Diabetes",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 1993
    }, {
      "title" : "Differential expression of glutamic acid decarboxylase in rat and human islets",
      "author" : [ "JS Petersen", "S Russel", "MO Marshall", "H Kofod", "K Buschard", "N Cambon", "AE Karlsen", "E Boel", "WA Hagopian", "KR Hejnaes" ],
      "venue" : "Diabetes",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 1993
    }, {
      "title" : "Glutamate decarboxylase and GABA in pancreatic islets: lessons from knock-out mice",
      "author" : [ "SF Kash", "BG Condie", "S. Baekkeskov" ],
      "venue" : "Horm Metab Res",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 1999
    }, {
      "title" : "Pancreatic beta cells express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa hydrophilic form and a 64-kDa amphiphilic form which can be both membrane-bound and soluble",
      "author" : [ "S Christgau", "H Schierbeck", "HJ Aanstoot", "L Aagaard", "K Begley", "H Kofod", "K Hejnaes", "S. Baekkeskov" ],
      "venue" : "J Biol Chem",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 1991
    }, {
      "title" : "Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain",
      "author" : [ "S Christgau", "HJ Aanstoot", "H Schierbeck", "K Begley", "S Tullin", "K Hejnaes", "S. Baekkeskov" ],
      "venue" : "J Cell Biol",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 1992
    }, {
      "title" : "Amino acid residues 24-31 but not palmitoylation of cysteines 30 and 45 are required for membrane anchoring of glutamic acid decarboxylase, GAD65",
      "author" : [ "Y Shi", "B Veit", "S. Baekkeskov" ],
      "venue" : "J Cell Biol",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 1994
    }, {
      "title" : "A combination of three distinct trafficking signals mediates axonal targeting and presynaptic clustering of GAD65",
      "author" : [ "J Kanaani", "AE El-Husseini", "A Aguilera-Moreno", "JM Diacovo", "DS Bredt", "S. Baekkeskov" ],
      "venue" : "J Cell Biol",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2002
    }, {
      "title" : "A palmitoylation cycle dynamically regulates partitioning of the GABA-synthesizing enzyme GAD65 between ER-Golgi and post-Golgi membranes",
      "author" : [ "J Kanaani", "G Patterson", "F Schaufele", "J Lippincott-Schwartz", "S. Baekkeskov" ],
      "venue" : "J Cell Sci",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2008
    }, {
      "title" : "Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins",
      "author" : [ "K Huang", "A Yanai", "R Kang", "P Arstikaitis", "RR Singaraja", "M Metzler", "A Mullard", "B Haigh", "C Gauthier-Campbell", "CA Gutekunst", "MR Hayden", "A. El-Husseini" ],
      "venue" : "Neuron",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2004
    }, {
      "title" : "Palmitoylation controls trafficking of GAD65 from Golgi membranes to axon-specific endosomes and a Rab5adependent pathway to presynaptic clusters",
      "author" : [ "J Kanaani", "MJ Diacovo", "AE El-Husseini", "DS Bredt", "S. Baekkeskov" ],
      "venue" : "J Cell Sci 2004;117:2001-2013",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2013
    }, {
      "title" : "Compartmentalization of GABA Synthesis by GAD67 Differs between Pancreatic Beta Cells and Neurons",
      "author" : [ "J Kanaani", "C Cianciaruso", "EA Phelps", "M Pasquier", "E Brioudes", "N Billestrup", "S. Baekkeskov" ],
      "venue" : "PLoS One 2015;10:e0117130",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2015
    }, {
      "title" : "Palmitoylation cycles and regulation of protein function (Review)",
      "author" : [ "S Baekkeskov", "J. Kanaani" ],
      "venue" : "Mol Membr Biol",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2009
    }, {
      "title" : "Protein palmitoylation in neuronal development and synaptic plasticity",
      "author" : [ "Y Fukata", "M. Fukata" ],
      "venue" : "Nat Rev Neurosci",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2010
    }, {
      "title" : "The role of endoplasmic reticulum stress in human pathology",
      "author" : [ "Oakes SA", "Papa FR" ],
      "venue" : "Annu Rev Pathol",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2015
    }, {
      "title" : "The role for endoplasmic reticulum stress in diabetes mellitus",
      "author" : [ "DL Eizirik", "AK Cardozo", "M. Cnop" ],
      "venue" : "Endocr Rev 2008;29:42-61",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2008
    }, {
      "title" : "Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes",
      "author" : [ "I Marhfour", "XM Lopez", "D Lefkaditis", "I Salmon", "F Allagnat", "SJ Richardson", "NG Morgan", "DL. Eizirik" ],
      "venue" : "Diabetologia",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2012
    }, {
      "title" : "Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes",
      "author" : [ "F Engin", "A Yermalovich", "T Nguyen", "S Hummasti", "W Fu", "DL Eizirik", "D Mathis", "GS. Hotamisligil" ],
      "venue" : "Sci Transl Med",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2013
    }, {
      "title" : "Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes",
      "author" : [ "B Song", "D Scheuner", "D Ron", "S Pennathur", "RJ. Kaufman" ],
      "venue" : "J Clin Invest",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2008
    }, {
      "title" : "The role of inflammation in insulitis and beta-cell loss in type 1 diabetes",
      "author" : [ "DL Eizirik", "ML Colli", "F. Ortis" ],
      "venue" : "Nat Rev Endocrinol",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2009
    }, {
      "title" : "Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells",
      "author" : [ "A Merglen", "S Theander", "B Rubi", "G Chaffard", "CB Wollheim", "P. Maechler" ],
      "venue" : "Endocrinology",
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 2004
    }, {
      "title" : "Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope",
      "author" : [ "JC Jaume", "SL Parry", "AM Madec", "G Sonderstrup", "S. Baekkeskov" ],
      "venue" : "J Immunol",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2002
    }, {
      "title" : "Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401",
      "author" : [ "LS Wicker", "SL Chen", "GT Nepom", "JF Elliott", "DC Freed", "A Bansal", "S Zheng", "A Herman", "A Lernmark", "DM Zaller", "LB Peterson", "JB Rothbard", "R Cummings", "PJ. Whiteley" ],
      "venue" : "J Clin Invest",
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 1996
    }, {
      "title" : "Synergistic control of protein kinase Cgamma activity by ionotropic and metabotropic glutamate receptor inputs in hippocampal neurons",
      "author" : [ "F Codazzi", "A Di Cesare", "N Chiulli", "A Albanese", "T Meyer", "D Zacchetti", "F. Grohovaz" ],
      "venue" : "J Neurosci",
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2006
    }, {
      "title" : "Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes",
      "author" : [ "M Campbell-Thompson", "C Wasserfall", "J Kaddis", "A Albanese-O'Neill", "T Staeva", "C Nierras", "J Moraski", "P Rowe", "R Gianani", "G Eisenbarth", "J Crawford", "D Schatz", "A Pugliese", "M. Atkinson" ],
      "venue" : "Diabetes Metab Res Rev 2012;28:608-617",
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2012
    }, {
      "title" : "The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings",
      "author" : [ "A Pugliese", "M Yang", "I Kusmarteva", "T Heiple", "F Vendrame", "C Wasserfall", "P Rowe", "JM Moraski", "S Ball", "L Jebson", "DA Schatz", "R Gianani", "GW Burke", "C Nierras", "T Staeva", "JS Kaddis", "M Campbell-Thompson", "MA. Atkinson" ],
      "venue" : "Pediatr Diabetes",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2014
    }, {
      "title" : "Insulitis and beta-Cell Mass in the Natural History of Type 1 Diabetes",
      "author" : [ "M Campbell-Thompson", "A Fu", "JS Kaddis", "C Wasserfall", "DA Schatz", "A Pugliese", "MA. Atkinson" ],
      "venue" : "Diabetes",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2016
    }, {
      "title" : "Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase",
      "author" : [ "Chang YC", "Gottlieb DI" ],
      "venue" : "J Neurosci",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 1988
    }, {
      "title" : "A novel monoclonal antibody specific for the N-terminal end of GAD65",
      "author" : [ "CS Hampe", "P Lundgren", "TL Daniels", "LP Hammerle", "SM Marcovina", "A. Lernmark" ],
      "venue" : "J Neuroimmunol",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2001
    }, {
      "title" : "Site-specific analysis of protein S-acylation by resin-assisted capture",
      "author" : [ "MT Forrester", "DT Hess", "JW Thompson", "R Hultman", "MA Moseley", "JS Stamler", "PJ. Casey" ],
      "venue" : "J Lipid Res",
      "citeRegEx" : "33",
      "shortCiteRegEx" : "33",
      "year" : 2011
    }, {
      "title" : "Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress",
      "author" : [ "I Kharroubi", "L Ladriere", "AK Cardozo", "Z Dogusan", "M Cnop", "DL. Eizirik" ],
      "venue" : "Endocrinology",
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2004
    }, {
      "title" : "Initiation and execution of lipotoxic ER stress in pancreatic beta-cells",
      "author" : [ "DA Cunha", "P Hekerman", "L Ladriere", "A Bazarra-Castro", "F Ortis", "MC Wakeham", "F Moore", "J Rasschaert", "AK Cardozo", "E Bellomo", "L Overbergh", "C Mathieu", "R Lupi", "T Hai", "A Herchuelz", "P Marchetti", "GA Rutter", "DL Eizirik", "M. Cnop" ],
      "venue" : "J Cell Sci 2008;121:2308-2318",
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 2008
    }, {
      "title" : "Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms",
      "author" : [ "F Brozzi", "TR Nardelli", "M Lopes", "I Millard", "J Barthson", "M Igoillo-Esteve", "FA Grieco", "O Villate", "JM Oliveira", "M Casimir", "M Bugliani", "F Engin", "GS Hotamisligil", "P Marchetti", "DL. Eizirik" ],
      "venue" : "Diabetologia",
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2015
    }, {
      "title" : "Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response",
      "author" : [ "A Bertolotti", "Y Zhang", "LM Hendershot", "HP Harding", "D. Ron" ],
      "venue" : "Nat Cell Biol",
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2000
    }, {
      "title" : "Two distinct mechanisms target GAD67 to vesicular pathways and presynaptic clusters",
      "author" : [ "J Kanaani", "J Kolibachuk", "H Martinez", "S. Baekkeskov" ],
      "venue" : "J Cell Biol",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2010
    }, {
      "title" : "Route of uptake of palmitoylated encephalitogenic peptides of myelin proteolipid protein by antigen-presenting cells: importance of the type of bond between lipid chain and peptide and relevance to autoimmunity",
      "author" : [ "NA Pfender", "S Grosch", "G Roussel", "M Koch", "E Trifilieff", "JM. Greer" ],
      "venue" : "J Immunol",
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2008
    }, {
      "title" : "GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes",
      "author" : [ "N Soltani", "H Qiu", "M Aleksic", "Y Glinka", "F Zhao", "R Liu", "Y Li", "N Zhang", "R Chakrabarti", "T Ng", "T Jin", "H Zhang", "WY Lu", "ZP Feng", "GJ Prud'homme", "Q. Wang" ],
      "venue" : "Proc Natl Acad Sci U S A",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2011
    }, {
      "title" : "Beta cell ER stress and the implications for immunogenicity in type 1 diabetes. Frontiers in cell and developmental biology",
      "author" : [ "ML Marre", "EA James", "JD. Piganelli" ],
      "venue" : null,
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2015
    }, {
      "title" : "Mechanisms of pancreatic betacell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005;54:S97-107",
      "author" : [ "M Cnop", "N Welsh", "JC Jonas", "A Jorns", "S Lenzen", "DL. Eizirik" ],
      "venue" : null,
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2005
    }, {
      "title" : "Sorcin links pancreatic β-Cell lipotoxicity to ER Ca2+ stores",
      "author" : [ "A Marmugi", "J Parnis", "X Chen", "L Carmichael", "J Hardy", "N Mannan", "P Marchetti", "L Piemonti", "D Bosco", "P Johnson", "JAM Shapiro", "C Cruciani-Guglielmacci", "C Magnan", "M Ibberson", "B Thorens", "HH Valdivia", "GA Rutter", "I. Leclerc" ],
      "venue" : "Diabetes",
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2016
    }, {
      "title" : "Calcium-dependent binding of brain glutamate decarboxylase to phospholipid vesicles",
      "author" : [ "M Covarrubias", "R. Tapia" ],
      "venue" : "J Neurochem 1978;31:1209-1214",
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 1978
    }, {
      "title" : "Alteration of endoplasmic reticulum lipid rafts contributes to lipotoxicity in pancreatic beta-cells",
      "author" : [ "E Boslem", "JM Weir", "G MacIntosh", "N Sue", "J Cantley", "PJ Meikle", "TJ. Biden" ],
      "venue" : "J Biol Chem",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 2013
    }, {
      "title" : "Palmitoylation regulates raft affinity for the majority of integral raft proteins",
      "author" : [ "I Levental", "D Lingwood", "M Grzybek", "U Coskun", "K. Simons" ],
      "venue" : "Proc Natl Acad Sci U S A",
      "citeRegEx" : "46",
      "shortCiteRegEx" : "46",
      "year" : 2054
    }, {
      "title" : "H-ras distribution and signaling in plasma membrane microdomains are regulated by acylation and deacylation events",
      "author" : [ "L Agudo-Ibanez", "A Herrero", "M Barbacid", "P. Crespo" ],
      "venue" : "Mol Cell Biol",
      "citeRegEx" : "47",
      "shortCiteRegEx" : "47",
      "year" : 1914
    }, {
      "title" : "Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene",
      "author" : [ "DF Bu", "MG Erlander", "BC Hitz", "NJ Tillakaratne", "DL Kaufman", "CB Wagner-McPherson", "GA Evans", "AJ. Tobin" ],
      "venue" : "Proc Natl Acad Sci U S A",
      "citeRegEx" : "48",
      "shortCiteRegEx" : "48",
      "year" : 1992
    }, {
      "title" : "The hydrophilic isoform of glutamate decarboxylase, GAD67, is targeted to membranes and nerve terminals independent of dimerization with the hydrophobic membrane-anchored isoform, GAD65",
      "author" : [ "J Kanaani", "D Lissin", "SF Kash", "S. Baekkeskov" ],
      "venue" : "J Biol Chem",
      "citeRegEx" : "49",
      "shortCiteRegEx" : "49",
      "year" : 1999
    }, {
      "title" : "Thiopalmitoylation of myelin proteolipid protein epitopes enhances immunogenicity and encephalitogenicity",
      "author" : [ "JM Greer", "B Denis", "RA Sobel", "E. Trifilieff" ],
      "venue" : "J Immunol",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 2001
    }, {
      "title" : "Synthetic peptide vaccines: palmitoylation of peptide antigens by a thioester bond increases immunogenicity",
      "author" : [ "NJ Beekman", "WM Schaaper", "GI Tesser", "K Dalsgaard", "S Kamstrup", "JP Langeveld", "RS Boshuizen", "RH. Meloen" ],
      "venue" : "J Pept Res",
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 1997
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "INTRODUCTION The GABA-synthesizing enzyme glutamic acid decarboxylase (GAD) exists in two isoforms, GAD65 and GAD67, encoded by different genes (1).",
      "startOffset" : 144,
      "endOffset" : 147
    }, {
      "referenceID" : 1,
      "context" : "The smaller isoform, GAD65, is an early target of autoimmunity in 70-80% of patients who develop T1D (2-4).",
      "startOffset" : 101,
      "endOffset" : 106
    }, {
      "referenceID" : 2,
      "context" : "The smaller isoform, GAD65, is an early target of autoimmunity in 70-80% of patients who develop T1D (2-4).",
      "startOffset" : 101,
      "endOffset" : 106
    }, {
      "referenceID" : 3,
      "context" : "The smaller isoform, GAD65, is an early target of autoimmunity in 70-80% of patients who develop T1D (2-4).",
      "startOffset" : 101,
      "endOffset" : 106
    }, {
      "referenceID" : 4,
      "context" : "Rat and human beta cells primarily express GAD65, while no GAD65 is detected at the protein level in mouse beta cells (5; 6).",
      "startOffset" : 118,
      "endOffset" : 124
    }, {
      "referenceID" : 5,
      "context" : "Rat and human beta cells primarily express GAD65, while no GAD65 is detected at the protein level in mouse beta cells (5; 6).",
      "startOffset" : 118,
      "endOffset" : 124
    }, {
      "referenceID" : 6,
      "context" : "Our understanding of how GAD65 becomes an autoantigen in T1D is limited due to the lack of this protein in beta cells of mice, and therefore an apparent lack of a significant role in the pathogenesis of diabetes in the highly studied NOD mouse model of T1D (7).",
      "startOffset" : 257,
      "endOffset" : 260
    }, {
      "referenceID" : 7,
      "context" : "The GAD65 enzyme is synthesized in the cytosol as a hydrophilic cytosolic molecule, which undergoes hydrophobic post-translational modifications in the N-terminal domain to become membrane anchored (8-11).",
      "startOffset" : 198,
      "endOffset" : 204
    }, {
      "referenceID" : 8,
      "context" : "The GAD65 enzyme is synthesized in the cytosol as a hydrophilic cytosolic molecule, which undergoes hydrophobic post-translational modifications in the N-terminal domain to become membrane anchored (8-11).",
      "startOffset" : 198,
      "endOffset" : 204
    }, {
      "referenceID" : 9,
      "context" : "The GAD65 enzyme is synthesized in the cytosol as a hydrophilic cytosolic molecule, which undergoes hydrophobic post-translational modifications in the N-terminal domain to become membrane anchored (8-11).",
      "startOffset" : 198,
      "endOffset" : 204
    }, {
      "referenceID" : 10,
      "context" : "The GAD65 enzyme is synthesized in the cytosol as a hydrophilic cytosolic molecule, which undergoes hydrophobic post-translational modifications in the N-terminal domain to become membrane anchored (8-11).",
      "startOffset" : 198,
      "endOffset" : 204
    }, {
      "referenceID" : 11,
      "context" : "The first step of hydrophobic modifications is irreversible and results in a hydrophobic form that targets specifically to the cytosolic face of endoplasmic reticulum (ER) and cis-Golgi membranes, establishing an equilibrium between membrane and cytosolic pools (12).",
      "startOffset" : 262,
      "endOffset" : 266
    }, {
      "referenceID" : 9,
      "context" : "The second step of modifications, which include stabilization of membrane anchoring followed by a reversible double palmitoylation of cysteines 30 and 45 (10) by a Golgi localized protein acyl transferase (PAT) DHHC17 (also known as HIP14) (13), result in trapping of GAD65 in Golgi membranes, sorting to the trans-Golgi network (TGN) and targeting to an axonal vesicular pathway in route to synaptic vesicles in presynaptic clusters in neurons and to peripheral vesicles in beta cells (12; 14; 15).",
      "startOffset" : 154,
      "endOffset" : 158
    }, {
      "referenceID" : 12,
      "context" : "The second step of modifications, which include stabilization of membrane anchoring followed by a reversible double palmitoylation of cysteines 30 and 45 (10) by a Golgi localized protein acyl transferase (PAT) DHHC17 (also known as HIP14) (13), result in trapping of GAD65 in Golgi membranes, sorting to the trans-Golgi network (TGN) and targeting to an axonal vesicular pathway in route to synaptic vesicles in presynaptic clusters in neurons and to peripheral vesicles in beta cells (12; 14; 15).",
      "startOffset" : 240,
      "endOffset" : 244
    }, {
      "referenceID" : 11,
      "context" : "The second step of modifications, which include stabilization of membrane anchoring followed by a reversible double palmitoylation of cysteines 30 and 45 (10) by a Golgi localized protein acyl transferase (PAT) DHHC17 (also known as HIP14) (13), result in trapping of GAD65 in Golgi membranes, sorting to the trans-Golgi network (TGN) and targeting to an axonal vesicular pathway in route to synaptic vesicles in presynaptic clusters in neurons and to peripheral vesicles in beta cells (12; 14; 15).",
      "startOffset" : 486,
      "endOffset" : 498
    }, {
      "referenceID" : 13,
      "context" : "The second step of modifications, which include stabilization of membrane anchoring followed by a reversible double palmitoylation of cysteines 30 and 45 (10) by a Golgi localized protein acyl transferase (PAT) DHHC17 (also known as HIP14) (13), result in trapping of GAD65 in Golgi membranes, sorting to the trans-Golgi network (TGN) and targeting to an axonal vesicular pathway in route to synaptic vesicles in presynaptic clusters in neurons and to peripheral vesicles in beta cells (12; 14; 15).",
      "startOffset" : 486,
      "endOffset" : 498
    }, {
      "referenceID" : 14,
      "context" : "The second step of modifications, which include stabilization of membrane anchoring followed by a reversible double palmitoylation of cysteines 30 and 45 (10) by a Golgi localized protein acyl transferase (PAT) DHHC17 (also known as HIP14) (13), result in trapping of GAD65 in Golgi membranes, sorting to the trans-Golgi network (TGN) and targeting to an axonal vesicular pathway in route to synaptic vesicles in presynaptic clusters in neurons and to peripheral vesicles in beta cells (12; 14; 15).",
      "startOffset" : 486,
      "endOffset" : 498
    }, {
      "referenceID" : 11,
      "context" : "Palmitoylation is not required for anchoring of GAD65 to Golgi membranes but is critical for anterograde targeting of GAD65 from cis-Golgi to TGN membranes and post-Golgi peripheral vesicles (12).",
      "startOffset" : 191,
      "endOffset" : 195
    }, {
      "referenceID" : 11,
      "context" : "The protein can then enter a cycle of re-palmitoylation and de-palmitoylation (12).",
      "startOffset" : 78,
      "endOffset" : 82
    }, {
      "referenceID" : 15,
      "context" : "Palmitoylation is suggested to serve a critical function in regulating the rate of GABA synthesis in the presynaptic compartment of neurons (16; 17).",
      "startOffset" : 140,
      "endOffset" : 148
    }, {
      "referenceID" : 16,
      "context" : "Palmitoylation is suggested to serve a critical function in regulating the rate of GABA synthesis in the presynaptic compartment of neurons (16; 17).",
      "startOffset" : 140,
      "endOffset" : 148
    }, {
      "referenceID" : 17,
      "context" : "When the protein synthesis and secretion machinery becomes overloaded, either due to a high physiological demand on a limited number of cells or from exogenous stressors such as inflammation or a diet high in fatty acids, the accumulation of unfolded and improperly folded proteins transiting through the ER results in the cell experiencing a state of ER stress (18).",
      "startOffset" : 362,
      "endOffset" : 366
    }, {
      "referenceID" : 18,
      "context" : "Beta cells are highly sensitive to ER stress, which is implicated in the pathogenesis of T1D (19-22).",
      "startOffset" : 93,
      "endOffset" : 100
    }, {
      "referenceID" : 19,
      "context" : "Beta cells are highly sensitive to ER stress, which is implicated in the pathogenesis of T1D (19-22).",
      "startOffset" : 93,
      "endOffset" : 100
    }, {
      "referenceID" : 20,
      "context" : "Beta cells are highly sensitive to ER stress, which is implicated in the pathogenesis of T1D (19-22).",
      "startOffset" : 93,
      "endOffset" : 100
    }, {
      "referenceID" : 21,
      "context" : "Beta cells are highly sensitive to ER stress, which is implicated in the pathogenesis of T1D (19-22).",
      "startOffset" : 93,
      "endOffset" : 100
    }, {
      "referenceID" : 18,
      "context" : "It has been proposed that the initiation of autoimmunity against the beta cell follows an initial period of prolonged beta cell ER stress and apoptosis, induced by inflammatory cytokines secreted by early invading immune cells as well as the beta cells themselves (19; 23).",
      "startOffset" : 264,
      "endOffset" : 272
    }, {
      "referenceID" : 22,
      "context" : "It has been proposed that the initiation of autoimmunity against the beta cell follows an initial period of prolonged beta cell ER stress and apoptosis, induced by inflammatory cytokines secreted by early invading immune cells as well as the beta cells themselves (19; 23).",
      "startOffset" : 264,
      "endOffset" : 272
    }, {
      "referenceID" : 23,
      "context" : "Cell cultures INS-1E rat insulinoma cells (24) were cultured in RPMI 1640 with GlutaMAX, 10% FBS, 1% Penicillin/Streptomycin (P/S), 1 mM sodium pyruvate, 10 mM HEPES, and 50 μM βmercaptoethanol.",
      "startOffset" : 42,
      "endOffset" : 46
    }, {
      "referenceID" : 24,
      "context" : "The DR4 (DRA1*0101, DRB1*0401) positive human EBV-transformed B cell line Priess (25) was cultured in IMDM GlutaMAX medium with 10% FBS, and 1% P/S.",
      "startOffset" : 81,
      "endOffset" : 85
    }, {
      "referenceID" : 25,
      "context" : "1, recognizing the GAD65 aa 274-286 epitope (GAD65(274-286)) (26), was cultured in RPMI 1640 with GlutaMAX, 10% FBS, 1% P/S, and 0.",
      "startOffset" : 61,
      "endOffset" : 65
    }, {
      "referenceID" : 26,
      "context" : "Primary rat hippocampal neurons were prepared from 2- to 3-day-old Sprague Dawley rats as described by Codazzi et al (27).",
      "startOffset" : 117,
      "endOffset" : 121
    }, {
      "referenceID" : 14,
      "context" : "Rat islets isolated from P5 Sprague Dawley rats as previously described (15) were cultured in RPMI 1640, 10% FBS, and 1% P/S at 37°C, 5% CO2.",
      "startOffset" : 72,
      "endOffset" : 76
    }, {
      "referenceID" : 27,
      "context" : "Human pancreatic sections Human pancreatic sections were obtained from the Juvenile Diabetes Research Foundation (JDRF) Network for Pancreatic Organ Donors with Diabetes (nPOD) tissue bank (28; 29).",
      "startOffset" : 189,
      "endOffset" : 197
    }, {
      "referenceID" : 28,
      "context" : "Human pancreatic sections Human pancreatic sections were obtained from the Juvenile Diabetes Research Foundation (JDRF) Network for Pancreatic Organ Donors with Diabetes (nPOD) tissue bank (28; 29).",
      "startOffset" : 189,
      "endOffset" : 197
    }, {
      "referenceID" : 29,
      "context" : "Insulitis is defined by nPOD as the presence of 6 or more CD3+ T cells immediately adjacent to or within 3 or more islets of a defined minimum size in pancreatic sections (30).",
      "startOffset" : 171,
      "endOffset" : 175
    }, {
      "referenceID" : 30,
      "context" : "Primary antibodies (CHOP, Santa Cruz, sc-575, 1:100; GAD6, mouse monoclonal antibody against Cterminus of GAD65 (31), 1:1000; N-GAD65 mAb, mouse monoclonal antibody against Nterminus of GAD65 (32), 1:300; Giantin, Abcam, ab24586, 1:1000; Insulin, Linco 4011-01, 1:10,000; Insulin, Abcam, ab14042, 1:2,000; CD3, Dako M7254, 1:30) were incubated overnight at 4°C in PBS + 0.",
      "startOffset" : 112,
      "endOffset" : 116
    }, {
      "referenceID" : 31,
      "context" : "Primary antibodies (CHOP, Santa Cruz, sc-575, 1:100; GAD6, mouse monoclonal antibody against Cterminus of GAD65 (31), 1:1000; N-GAD65 mAb, mouse monoclonal antibody against Nterminus of GAD65 (32), 1:300; Giantin, Abcam, ab24586, 1:1000; Insulin, Linco 4011-01, 1:10,000; Insulin, Abcam, ab14042, 1:2,000; CD3, Dako M7254, 1:30) were incubated overnight at 4°C in PBS + 0.",
      "startOffset" : 192,
      "endOffset" : 196
    }, {
      "referenceID" : 4,
      "context" : "GAD65 and GAD67 (5), 1:5000) overnight at 4°C, and detected with secondary antibody IRDye 800CW (LI-COR Biosciences).",
      "startOffset" : 16,
      "endOffset" : 19
    }, {
      "referenceID" : 10,
      "context" : "Generation of GAD65-GFP and GAD65(C30,45A)-GFP was described previously (11; 12; 14).",
      "startOffset" : 72,
      "endOffset" : 84
    }, {
      "referenceID" : 11,
      "context" : "Generation of GAD65-GFP and GAD65(C30,45A)-GFP was described previously (11; 12; 14).",
      "startOffset" : 72,
      "endOffset" : 84
    }, {
      "referenceID" : 13,
      "context" : "Generation of GAD65-GFP and GAD65(C30,45A)-GFP was described previously (11; 12; 14).",
      "startOffset" : 72,
      "endOffset" : 84
    }, {
      "referenceID" : 27,
      "context" : "Human pancreatic sections obtained via the nPOD tissue bank, University of Florida, Gainesville, FL, USA were harvested from cadaveric organ donors by certified organ procurement organizations partnering with nPOD in accordance with organ donation laws and regulations and classified as “Non-Human Subjects” by the University of Florida Institutional Review Board (28; 29).",
      "startOffset" : 364,
      "endOffset" : 372
    }, {
      "referenceID" : 28,
      "context" : "Human pancreatic sections obtained via the nPOD tissue bank, University of Florida, Gainesville, FL, USA were harvested from cadaveric organ donors by certified organ procurement organizations partnering with nPOD in accordance with organ donation laws and regulations and classified as “Non-Human Subjects” by the University of Florida Institutional Review Board (28; 29).",
      "startOffset" : 364,
      "endOffset" : 372
    }, {
      "referenceID" : 14,
      "context" : "As previously reported (15), GAD65 is detected diffuse in the cytosol as well as in Golgi membranes and post-Golgi vesicles in beta cells.",
      "startOffset" : 23,
      "endOffset" : 27
    }, {
      "referenceID" : 33,
      "context" : "To induce mild ER stress, primary islet cell monolayers were subjected to a 48 h time course of low levels (10 U/ml) of the inflammatory cytokines IL-1β and IFNγ or overnight treatment with the saturated fatty acid palmitate (500 μM) (Figure 2), both of which have been previously shown to trigger ER stress in beta cells (34-36).",
      "startOffset" : 322,
      "endOffset" : 329
    }, {
      "referenceID" : 34,
      "context" : "To induce mild ER stress, primary islet cell monolayers were subjected to a 48 h time course of low levels (10 U/ml) of the inflammatory cytokines IL-1β and IFNγ or overnight treatment with the saturated fatty acid palmitate (500 μM) (Figure 2), both of which have been previously shown to trigger ER stress in beta cells (34-36).",
      "startOffset" : 322,
      "endOffset" : 329
    }, {
      "referenceID" : 35,
      "context" : "To induce mild ER stress, primary islet cell monolayers were subjected to a 48 h time course of low levels (10 U/ml) of the inflammatory cytokines IL-1β and IFNγ or overnight treatment with the saturated fatty acid palmitate (500 μM) (Figure 2), both of which have been previously shown to trigger ER stress in beta cells (34-36).",
      "startOffset" : 322,
      "endOffset" : 329
    }, {
      "referenceID" : 36,
      "context" : "Cells were also treated for 8 h with thapsigargin, which is a potent ER stress inducing agent (37) (Figure 2).",
      "startOffset" : 94,
      "endOffset" : 98
    }, {
      "referenceID" : 11,
      "context" : "Accumulation of GAD65 in the Golgi compartment during induction of ER stress by either palmitate or thapsigargin was confirmed by co-staining for the Golgi marker giantin (Figure 3A, Supplementary Figure 1A-C) but Golgi structures are also clearly identifiable by GAD65 localization in both beta cells and neurons (12; 15; 38).",
      "startOffset" : 314,
      "endOffset" : 326
    }, {
      "referenceID" : 14,
      "context" : "Accumulation of GAD65 in the Golgi compartment during induction of ER stress by either palmitate or thapsigargin was confirmed by co-staining for the Golgi marker giantin (Figure 3A, Supplementary Figure 1A-C) but Golgi structures are also clearly identifiable by GAD65 localization in both beta cells and neurons (12; 15; 38).",
      "startOffset" : 314,
      "endOffset" : 326
    }, {
      "referenceID" : 37,
      "context" : "Accumulation of GAD65 in the Golgi compartment during induction of ER stress by either palmitate or thapsigargin was confirmed by co-staining for the Golgi marker giantin (Figure 3A, Supplementary Figure 1A-C) but Golgi structures are also clearly identifiable by GAD65 localization in both beta cells and neurons (12; 15; 38).",
      "startOffset" : 314,
      "endOffset" : 326
    }, {
      "referenceID" : 11,
      "context" : "While palmitoylation of cysteines 30 and 45 is not required for firm anchoring of GAD65 to Golgi membranes, it is critical for its anterograde trafficking from cis-Golgi to TGN membranes and targeting to postGolgi vesicles (12).",
      "startOffset" : 223,
      "endOffset" : 227
    }, {
      "referenceID" : 11,
      "context" : "pools of the protein, a rapid pool and a slow pool (12).",
      "startOffset" : 51,
      "endOffset" : 55
    }, {
      "referenceID" : 38,
      "context" : "palmitoylation Given that modification of peptides and proteins by palmitoylation may enhance their immunogenicity (39), we assessed whether the palmitoylation state of GAD65 has an effect on its uptake by antigen presenting cells (APCs) and/or activation of T cells in an APC / T-cell coculture assay.",
      "startOffset" : 115,
      "endOffset" : 119
    }, {
      "referenceID" : 32,
      "context" : "Recombinant human GAD65 produced in yeast was depalmitoylated by thiol-acyl cleavage with hydroxylamine (HA), and depalmitoylation was confirmed biochemically by the S-acylation resin-assisted capture (Acyl-RAC) assay (33) (Figure 7A).",
      "startOffset" : 218,
      "endOffset" : 222
    }, {
      "referenceID" : 27,
      "context" : "Human pancreatic sections provided by the nPOD tissue bank (28; 29) representing 8 healthy donors (Supplementary Table 1), 8 potentially prediabetic individuals positive for GAD65 autoantibodies (GADA+) (Supplementary Table 2), and 8 T1D patients with residual beta cell mass (Supplementary Table 3) were immunostained for GAD65, giantin, insulin, glucagon and the pan-T cell marker CD3 (Figure 8A-D).",
      "startOffset" : 59,
      "endOffset" : 67
    }, {
      "referenceID" : 28,
      "context" : "Human pancreatic sections provided by the nPOD tissue bank (28; 29) representing 8 healthy donors (Supplementary Table 1), 8 potentially prediabetic individuals positive for GAD65 autoantibodies (GADA+) (Supplementary Table 2), and 8 T1D patients with residual beta cell mass (Supplementary Table 3) were immunostained for GAD65, giantin, insulin, glucagon and the pan-T cell marker CD3 (Figure 8A-D).",
      "startOffset" : 59,
      "endOffset" : 67
    }, {
      "referenceID" : 29,
      "context" : "The highest Golgi accumulation observed in the T1D group was observed in a double autoantibody positive (GADA+ and mIAA+) 11-year-old individual expressing the T1D HLAclass II susceptibility haplotypes DR3, DQ2 and DR4, DQ8 and with ongoing insulitis (Supplementary Table 3) (30) as confirmed by our CD3 immunostaining (Figure 8A, nPOD 6265).",
      "startOffset" : 275,
      "endOffset" : 279
    }, {
      "referenceID" : 11,
      "context" : "We have shown earlier that palmitoylation of GAD65 results in anterograde trafficking from cis-Golgi to TGN membranes (12).",
      "startOffset" : 118,
      "endOffset" : 122
    }, {
      "referenceID" : 39,
      "context" : "GABA serves as an important signaling molecule and survival/growth factor in islets of Langerhans (40).",
      "startOffset" : 98,
      "endOffset" : 102
    }, {
      "referenceID" : 33,
      "context" : "The mechanisms by which cytokines, palmitate, and thapsigargin induce ER stress in beta cells may differ (34).",
      "startOffset" : 105,
      "endOffset" : 109
    }, {
      "referenceID" : 40,
      "context" : "One commonality between the three different treatments is that each is implicated in dysregulation of calcium homeostasis (41).",
      "startOffset" : 122,
      "endOffset" : 126
    }, {
      "referenceID" : 41,
      "context" : "Both inflammatory cytokines and thapsigargin have been shown to induce beta cell ER stress through downregulation or inhibition of the sarco/endoplasmic reticulum Ca ATPase, resulting in elevation of cytosolic calcium concentrations and depletion of ER Ca stores (42).",
      "startOffset" : 263,
      "endOffset" : 267
    }, {
      "referenceID" : 34,
      "context" : "Palmitate is reported to induce ER stress through lipotoxic signaling pathways mediating a block in ER uptake of Ca and a sustained depletion of ER Ca stores (35; 43).",
      "startOffset" : 158,
      "endOffset" : 166
    }, {
      "referenceID" : 42,
      "context" : "Palmitate is reported to induce ER stress through lipotoxic signaling pathways mediating a block in ER uptake of Ca and a sustained depletion of ER Ca stores (35; 43).",
      "startOffset" : 158,
      "endOffset" : 166
    }, {
      "referenceID" : 43,
      "context" : "While it is currently unknown how a change in calcium homeostasis could affect membrane trafficking of GAD65, it is of note that earlier studies have suggested modulation of the affinity of GAD65 to liposome membranes by calcium ion concentration (44).",
      "startOffset" : 247,
      "endOffset" : 251
    }, {
      "referenceID" : 44,
      "context" : "Interestingly, there is evidence to suggest that palmitate treatment of insulinoma cells alters the lipid composition of endomembranes and specifically disrupts lipid raft microdomains (45), a dynamic hub for palmitoylated proteins (46).",
      "startOffset" : 185,
      "endOffset" : 189
    }, {
      "referenceID" : 45,
      "context" : "Interestingly, there is evidence to suggest that palmitate treatment of insulinoma cells alters the lipid composition of endomembranes and specifically disrupts lipid raft microdomains (45), a dynamic hub for palmitoylated proteins (46).",
      "startOffset" : 232,
      "endOffset" : 236
    }, {
      "referenceID" : 46,
      "context" : "It is of note that distribution of H-Ras into lipid rafts is regulated by its palmitoylation/depalmitoylation cycle (47), which shares similarities with the acylation cycle of GAD65 (16).",
      "startOffset" : 116,
      "endOffset" : 120
    }, {
      "referenceID" : 15,
      "context" : "It is of note that distribution of H-Ras into lipid rafts is regulated by its palmitoylation/depalmitoylation cycle (47), which shares similarities with the acylation cycle of GAD65 (16).",
      "startOffset" : 182,
      "endOffset" : 186
    }, {
      "referenceID" : 1,
      "context" : "initiation of autoimmunity Parallel to the important role of GAD65 as the highly regulated and the only GABA synthesizing enzyme in human beta cells, it can assume a detrimental role as a major target of autoimmunity associated with pancreatic human beta cell destruction and development of T1D in genetically susceptible individuals (2).",
      "startOffset" : 334,
      "endOffset" : 337
    }, {
      "referenceID" : 47,
      "context" : "GAD67 primarily differs from GAD65 in the N-terminal domain (48) that mediates hydrophobic post-translational modifications, membrane anchoring, palmitoylation and trafficking of GAD65 (12), suggesting that this region is integral to the susceptibility of GAD65 to become a pathogenic auto-antigen.",
      "startOffset" : 60,
      "endOffset" : 64
    }, {
      "referenceID" : 11,
      "context" : "GAD67 primarily differs from GAD65 in the N-terminal domain (48) that mediates hydrophobic post-translational modifications, membrane anchoring, palmitoylation and trafficking of GAD65 (12), suggesting that this region is integral to the susceptibility of GAD65 to become a pathogenic auto-antigen.",
      "startOffset" : 185,
      "endOffset" : 189
    }, {
      "referenceID" : 48,
      "context" : "GAD67 does not undergo hydrophobic modifications (49) and can only be targeted to membranes by piggy-backing onto other proteins (15; 38).",
      "startOffset" : 49,
      "endOffset" : 53
    }, {
      "referenceID" : 14,
      "context" : "GAD67 does not undergo hydrophobic modifications (49) and can only be targeted to membranes by piggy-backing onto other proteins (15; 38).",
      "startOffset" : 129,
      "endOffset" : 137
    }, {
      "referenceID" : 37,
      "context" : "GAD67 does not undergo hydrophobic modifications (49) and can only be targeted to membranes by piggy-backing onto other proteins (15; 38).",
      "startOffset" : 129,
      "endOffset" : 137
    }, {
      "referenceID" : 49,
      "context" : "Palmitoylation of peptide epitopes has been shown to enhance immunogenicity of autoimmune epitopes in experimental autoimmune encephalomyelitis (50) and in synthetic peptide vaccines (51).",
      "startOffset" : 144,
      "endOffset" : 148
    }, {
      "referenceID" : 50,
      "context" : "Palmitoylation of peptide epitopes has been shown to enhance immunogenicity of autoimmune epitopes in experimental autoimmune encephalomyelitis (50) and in synthetic peptide vaccines (51).",
      "startOffset" : 183,
      "endOffset" : 187
    } ],
    "year" : 2016,
    "abstractText" : "Pancreatic islet beta cells are particularly susceptible to endoplasmic reticulum (ER) stress, which is implicated in beta cell dysfunction and loss during the pathogenesis of type 1 diabetes (T1D). The peripheral membrane protein GAD65 is an autoantigen in human T1D. GAD65 synthesizes GABA, an important autocrine and paracrine signaling molecule and a survival factor in islets. We show that ER stress in primary beta cells perturbs the palmitoylation cycle controlling GAD65 endomembrane distribution, resulting in aberrant accumulation of the palmitoylated form in trans-Golgi membranes. The palmitoylated form has heightened immunogenicity, exhibiting increased uptake by antigen presenting cells and T cell stimulation compared to the non-palmitoylated form. Similar accumulation of GAD65 in Golgi membranes is observed in human beta cells in pancreatic sections from GAD65 autoantibody positive individuals, who have not yet progressed to clinical onset of T1D, and T1D patients with residual beta cell mass and ongoing T cell infiltration of islets. We propose that aberrant accumulation of immunogenic GAD65 in Golgi membranes facilitates inappropriate presentation to the immune system following release from stressed and/or damaged beta cells, triggering autoimmunity. Page 3 of 50 Diabetes",
    "creator" : "SPDF"
  }
}